Bardet-Biedl syndrome

Mendelian MONDO:0015229 Pathograph 40 Syndromic Obesity Ciliopathy

Bardet-Biedl syndrome is a genetically heterogeneous autosomal recessive ciliopathy caused by biallelic pathogenic variants in established BBS genes encoding the BBSome, its chaperonin-like assembly machinery, and closely related ciliary trafficking proteins. The core disease logic is failure of primary-cilium cargo trafficking, producing retinal degeneration, early-onset obesity with hyperphagia, postaxial polydactyly, and structurally and functionally abnormal kidneys.

Ask OpenScientist

Ask a research question about Bardet-Biedl syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

2
Inheritance
11
Pathophys.
15
Phenotypes
40
Pathograph
26
Genes
2
Medical Actions
1
References
3
Deep Research
🏷

Classifications

Harrison's Chapter
GENETICS_ENVIRONMENT_DISEASE
Mechanistic Nosology
ciliopathy
👪

Inheritance

2
Autosomal recessive inheritance HP:0000007
Classic Bardet-Biedl syndrome is an autosomal recessive syndromic ciliopathy.
Autosomal recessive inheritance
Show evidence (2 references)
PMID:20876674 SUPPORT Human Clinical
"Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a wide spectrum of clinical features including obesity, retinitis pigmentosa, polydactyly, mental retardation, hypogonadism, and renal abnormalities."
This cohort abstract explicitly states autosomal recessive inheritance for classic BBS.
ORPHA:110 SUPPORT Other
"Autosomal recessive"
Orphanet classifies Bardet-Biedl syndrome as autosomal recessive inheritance.
Oligogenic inheritance
A subset of BBS families show evidence of oligogenic (triallelic) inheritance, where variants at a second BBS locus are required to manifest the phenotype.
Oligogenic inheritance
Show evidence (2 references)
ORPHA:110 SUPPORT Other
"Oligogenic"
Orphanet lists oligogenic as an additional inheritance pattern for Bardet-Biedl syndrome.
PMID:11567139 SUPPORT Human Clinical
"We therefore propose that BBS may not be a single-gene recessive disease but a complex trait requiring three mutant alleles to manifest the phenotype."
The landmark Katsanis et al. 2001 paper provides direct evidence for triallelic/oligogenic inheritance in BBS families.
⚙

Pathophysiology

11
Pathogenic BBS gene defects
Biallelic pathogenic variants in any of the >20 established BBS genes initiate classic Bardet-Biedl syndrome. The genes partition into four functional modules that converge on a common ciliary trafficking defect: BBSome subunits, the BBS-chaperonin assembly complex, the ARL6/IFT membrane-recruitment and transport machinery, and transition-zone/basal-body gatekeeping proteins.
BBS1 hgnc:966 BBS10 hgnc:26291 BBS2 hgnc:967 ARL6 hgnc:13210 MKKS hgnc:7108 CEP290 hgnc:29021
Downstream
BBSome subunit deficiency Variants in BBSome subunit genes destabilize the eight-subunit core complex.
BBS-chaperonin assembly defect Variants in the chaperonin-like BBS genes impair assembly of the BBSome.
ARL6/IFT BBSome membrane recruitment and transport defect Variants in ARL6, LZTFL1, and IFT genes disrupt BBSome membrane recruitment and intraflagellar transport.
Ciliary transition zone and basal body dysfunction Variants in transition-zone and basal-body genes compromise the ciliary gate that the BBSome must traverse.
Show evidence (3 references)
PMID:30614526 SUPPORT Human Clinical
"Molecular diagnosis during pregnancies remains a timely challenge for this heterogeneous disease (22 known genes)."
This large prenatal molecular series supports disease initiation by biallelic pathogenic variants across many established BBS genes.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients, including three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in four patients, including two siblings."
This recent cohort confirms that clinically diagnosed BBS is anchored by biallelic pathogenic variants in established BBS genes.
ORPHA:110 SUPPORT Other
"A rare genetic multisystem disorder characterized by the variable association of retinal dystrophy, obesity, polydactyly, genitourinary and kidney anomalies, learning disability and hypogonadism"
Orphanet definition confirms BBS as a rare genetic multisystem disorder with the cardinal features anchored by pathogenic gene defects.
BBSome subunit deficiency
Pathogenic variants in core BBSome subunit genes destabilize the obligate eight-subunit BBSome, the membrane-coat complex that escorts signaling cargo out of cilia.
BBS1 hgnc:966 BBS2 hgnc:967 BBS4 hgnc:969 BBS5 hgnc:970 BBS7 hgnc:18758 TTC8 hgnc:20087 BBS9 hgnc:30000 BBIP1 hgnc:28093
BBSome GO:0034464
Downstream
Defective BBSome assembly Loss of a subunit prevents formation of a stable, functional BBSome.
Show evidence (1 reference)
PMID:22072986 SUPPORT In Vitro
"We also show that all BBSome subunits and BBS3 (also known as ARL6) are required for BBSome ciliary entry"
This study demonstrates that the full set of BBSome subunits is required for ciliary entry, so loss of any subunit gene compromises the complex.
BBS-chaperonin assembly defect
The chaperonin-like BBS proteins MKKS/BBS6, BBS10, and BBS12 form a BBS-chaperonin complex with CCT/TRiC that is required for ordered BBSome assembly; their loss prevents the BBSome from being built.
MKKS hgnc:7108 BBS10 hgnc:26291 BBS12 hgnc:26648
Downstream
Defective BBSome assembly Without the BBS-chaperonin complex, subunits cannot be folded and assembled into the BBSome.
Show evidence (2 references)
PMID:22500027 SUPPORT In Vitro
"Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a complex termed the BBS-chaperonin complex. This complex is required for BBSome assembly."
This mechanistic study directly supports chaperonin-dependent failure of BBSome assembly as an early causal step in BBS.
PMID:20080638 SUPPORT In Vitro
"Our data demonstrate that BBS6, BBS10, and BBS12 are necessary for BBSome assembly, and that impaired BBSome assembly contributes to the etiology of BBS phenotypes associated with the loss of function of these three BBS genes."
This complementary paper independently supports BBSome assembly failure as a proximal disease mechanism.
Defective BBSome assembly
Loss of core subunits or of the chaperonin assembly machinery prevents formation of the obligate BBSome, the ciliary membrane-coat trafficking complex central to BBS biology.
BBSome GO:0034464 primary cilium GO:0005929
Downstream
Ciliary membrane protein trafficking defect An incompletely assembled BBSome fails to move selected cargos correctly through the ciliary compartment.
Show evidence (1 reference)
PMID:31303482 SUPPORT In Vitro
"We find that BBSome subunits have a very high degree of interconnectivity, explaining the obligate nature of the complex."
The native-BBSome structure shows the subunits are highly interconnected and obligate, so loss of subunit or assembly factors disrupts the complex.
ARL6/IFT BBSome membrane recruitment and transport defect
The ARF-like GTPase ARL6/BBS3 recruits the autoinhibited BBSome to the ciliary membrane, where it couples to intraflagellar transport (IFT) trains; LZTFL1 regulates this trafficking. Loss of ARL6, LZTFL1, or IFT subunits blocks BBSome-dependent cargo movement even when the BBSome is intact.
ARL6 hgnc:13210 LZTFL1 hgnc:6741 IFT27 hgnc:18626 IFT74 hgnc:21424 IFT172 hgnc:30391
intraciliary transport GO:0042073
primary cilium GO:0005929
Downstream
Ciliary membrane protein trafficking defect Defective membrane recruitment and IFT coupling stall BBSome-dependent cargo transport.
Show evidence (3 references)
PMID:31303482 SUPPORT In Vitro
"the BBSome exists in an autoinhibited state in solution and must thus undergo a conformational change upon recruitment to membranes by the small GTPase ARL6/BBS3"
The structural study shows ARL6/BBS3 is required to recruit and activate the BBSome at the membrane, so ARL6 loss blocks BBSome function.
PMID:33587040 SUPPORT Model Organism
"GTP-bound BBS3 binds and recruits BBSomes to the ciliary membrane for interacting with PLD, thus making the PLD-laden BBSomes available to load onto retrograde IFT trains for ciliary exit."
This in vivo study shows ARL6/BBS3 recruits the BBSome to the membrane and couples it to retrograde IFT for ciliary exit of signaling cargo.
PMID:22072986 SUPPORT In Vitro
"LZTFL1), interacts with a BBS protein complex known as the BBSome and regulates ciliary trafficking of this complex"
LZTFL1 (BBS17) regulates BBSome ciliary trafficking, so its loss perturbs BBSome-dependent cargo movement.
Ciliary transition zone and basal body dysfunction
Transition-zone and basal-body BBS genes maintain the ciliary diffusion barrier and protein gate that the BBSome traverses. Their loss disrupts ciliary protein composition and produces BBS-like multisystem disease.
CEP290 hgnc:29021 MKS1 hgnc:7121 SDCCAG8 hgnc:10671 NPHP1 hgnc:7905 CEP19 hgnc:28209 SCLT1 hgnc:26406
cilium assembly GO:0060271 ↓ DECREASED protein localization to cilium GO:0061512 ⚠ ABNORMAL
ciliary transition zone GO:0035869 ciliary basal body GO:0036064
Downstream
Ciliary membrane protein trafficking defect A defective ciliary gate corrupts the ciliary protein composition the BBSome depends on.
Show evidence (1 reference)
PMID:24722439 SUPPORT Model Organism
"These mice exhibited early onset retinal degeneration that was associated with rhodopsin mislocalization in the photoreceptors and reduced cone cell numbers, and led to progressive loss of vision."
Loss of the transition-zone/centrosomal gene SDCCAG8 mislocalizes rhodopsin and degenerates photoreceptors, linking ciliary-gate dysfunction to the BBS retinal phenotype.
Ciliary membrane protein trafficking defect
Failure of an intact, membrane-recruited BBSome traversing a competent ciliary gate disrupts trafficking of signaling proteins and other cargos into and within the ciliary compartment.
protein localization to cilium GO:0061512 intraciliary transport GO:0042073
primary cilium GO:0005929
Downstream
Hypothalamic leptin receptor signaling defect Impaired neuronal ciliary trafficking perturbs hypothalamic satiety signaling.
Photoreceptor outer-segment transport defect High-throughput photoreceptor cargo delivery fails when ciliary trafficking is disrupted.
Renal tubulointerstitial injury Kidney epithelial cilia-dependent homeostasis is disrupted downstream of trafficking failure.
Altered Sonic hedgehog-dependent limb patterning Developmental ciliary signaling defects perturb limb-bud patterning.
Show evidence (1 reference)
PMID:36699005 SUPPORT Model Organism
"GPCR ciliary localization is disrupted in neurons from mouse models of the ciliopathy Bardet-Biedl syndrome, with GPCRs failing to localize to cilia, indicating the Bardet-Biedl syndrome proteins are required for trafficking of G protein-coupled receptors into neuronal cilia."
This mouse study directly supports defective ciliary cargo trafficking as a general mechanistic consequence of BBS protein loss.
Hypothalamic leptin receptor signaling defect
BBS proteins are required for leptin-receptor trafficking and leptin-induced hypothalamic signaling, creating ciliary leptin resistance and impaired satiety signaling.
neuron CL:0000540
JAK-STAT signaling GO:0007259
hypothalamus UBERON:0001898
Downstream
Hyperphagia Impaired satiety signaling increases hunger and food-seeking behavior.
Obesity Chronic positive energy balance drives early-onset obesity.
Show evidence (2 references)
PMID:19150989 SUPPORT Model Organism
"Our data indicate that BBS proteins mediate LepR trafficking and that impaired LepR signaling underlies energy imbalance in BBS."
This mouse study directly connects BBS-protein loss to defective hypothalamic leptin receptor trafficking and signaling.
PMID:21209035 SUPPORT Human Clinical
"Patients with BBS had higher leptin than expected for their degree of adiposity, consistent with the notion that ciliopathy-induced leptin signaling dysfunction is associated with leptin resistance."
Human metabolic data support leptin resistance as a clinically observable consequence of BBS-related satiety-pathway dysfunction.
Photoreceptor outer-segment transport defect
In photoreceptors, defective ciliary transport mislocalizes rhodopsin and other outer-segment cargo, leading to photoreceptor degeneration.
photoreceptor cell CL:0000210
photoreceptor outer segment GO:0001750
retina UBERON:0000966
Downstream
Rod-cone dystrophy Photoreceptor degeneration produces the invariant retinal dystrophy phenotype.
Progressive visual loss Ongoing photoreceptor loss causes worsening visual acuity over time.
Show evidence (1 reference)
PMID:15539463 SUPPORT Model Organism
"Photoreceptor cell death is preceded by mislocalization of rhodopsin, indicating a defect in transport."
This model-organism study directly ties BBS-related transport failure to the retinal degeneration branch of the disease.
Renal tubulointerstitial injury
Kidney involvement in BBS includes renal dysmorphism, impaired kidney function, and chronic tubulointerstitial disease consistent with a renal ciliopathy.
nephron tubule epithelial cell CL:1000494
kidney UBERON:0002113
Downstream
Renal abnormalities Structural and functional kidney disease is a major clinical consequence.
Show evidence (1 reference)
PMID:20876674 SUPPORT Human Clinical
"Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients."
This human cohort provides direct tissue-level support for renal tubulointerstitial disease within BBS.
Altered Sonic hedgehog-dependent limb patterning
BBS loss perturbs cilia-dependent Sonic hedgehog signaling during limb-bud development, predisposing to postaxial digit duplication.
smoothened signaling pathway GO:0007224
limb bud UBERON:0004347
Downstream
Postaxial polydactyly Disrupted limb-bud patterning manifests clinically as postaxial extra digits.
Show evidence (1 reference)
PMID:18381349 SUPPORT Model Organism
"We evaluated zebrafish fin bud patterning and observed altered Sonic hedgehog (shh) expression and subsequent changes to fin skeletal elements."
This in vivo developmental study supports altered hedgehog-dependent limb patterning as the mechanistic basis for BBS polydactyly.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Bardet-Biedl syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

15
Cardiovascular 1
Hypertension FREQUENT Hypertension HP:0000822
Show evidence (2 references)
ORPHA:110 SUPPORT Other
"HP:0000822 | Hypertension | Frequent (79-30%)"
Orphanet classifies hypertension as frequent (79-30%) in Bardet-Biedl syndrome.
PMID:20876674 SUPPORT Human Clinical
"Hypertension was found in >30% of the patients and hyperlipidemia in >60%"
This French cohort directly documents hypertension prevalence exceeding 30% in BBS patients.
Digestive 1
Hepatic fibrosis OCCASIONAL Hepatic fibrosis HP:0001395
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0001395 | Hepatic fibrosis | Occasional (29-5%)"
Orphanet classifies hepatic fibrosis as occasional (29-5%) in Bardet-Biedl syndrome.
Ear 1
Hearing impairment OCCASIONAL Hearing impairment HP:0000365
Show evidence (2 references)
ORPHA:110 SUPPORT Other
"HP:0000365 | Hearing impairment | Occasional (29-5%)"
Orphanet classifies hearing impairment as occasional (29-5%) in Bardet-Biedl syndrome.
PMID:28143435 SUPPORT Human Clinical
"BBS10 was associated with the worse outcome in terms of the renal, ocular and audiovestibular phenotypes."
This Italian cohort documents audiovestibular involvement in BBS, particularly associated with BBS10 genotype.
Endocrine 2
Hypogonadism FREQUENT Hypogonadism HP:0000135
Show evidence (2 references)
ORPHA:110 SUPPORT Other
"HP:0000135 | Hypogonadism | Frequent (79-30%)"
Orphanet classifies hypogonadism as frequent (79-30%) in Bardet-Biedl syndrome.
PMID:20876674 SUPPORT Human Clinical
"Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a wide spectrum of clinical features including obesity, retinitis pigmentosa, polydactyly, mental retardation, hypogonadism, and renal abnormalities."
This cohort explicitly lists hypogonadism among the cardinal clinical features of BBS.
Type II diabetes mellitus OCCASIONAL Type II diabetes mellitus HP:0005978
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0005978 | Type II diabetes mellitus | Occasional (29-5%)"
Orphanet classifies type II diabetes mellitus as occasional (29-5%) in Bardet-Biedl syndrome.
Eye 2
Rod-cone dystrophy VERY_FREQUENT Rod-cone dystrophy HP:0000510
Show evidence (3 references)
PMID:35886001 SUPPORT Human Clinical
"All patients had retinal dystrophy with morphologic changes of the retina."
This specialist ophthalmic cohort supports retinal dystrophy as an essentially invariant feature of molecularly confirmed BBS.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients ... Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
Molecularly confirmed BBS cohort (subject made explicit): retinal dystrophy at 94.1% supports the very frequent band, scoped to true BBS rather than the BBSome-opathy spectrum.
ORPHA:110 SUPPORT Other
"HP:0000556 | Retinal dystrophy | Obligate (100%)"
Orphanet classifies retinal dystrophy as obligate (100%) in Bardet-Biedl syndrome, supporting the very frequent designation.
Progressive visual loss Progressive visual loss HP:0000529
Show evidence (2 references)
PMID:35886001 SUPPORT Human Clinical
"Visual acuity decreased from ~0.2 (decimal) at age 5 to blindness 0 at 50 years."
This cohort provides direct longitudinal-style evidence for progressive loss of vision across the lifespan in BBS.
PMID:22358239 SUPPORT Human Clinical
"In a relatively young cohort of patients with Bardet-Biedl syndrome, only 21% had 20/40 or better vision."
This retinal-function study supports clinically important visual loss even in a relatively young cohort.
Genitourinary 1
Renal abnormalities FREQUENT Abnormality of the kidney HP:0000077
Show evidence (3 references)
PMID:20876674 SUPPORT Human Clinical
"Renal abnormalities, including impairment of renal function and signs of chronic interstitial nephropathy of dysplastic nature, were documented in 82% of the patients."
This national cohort supports renal involvement as a frequent and clinically important component of BBS.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients ... Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
Molecularly confirmed BBS cohort (subject made explicit): renal involvement at 52% remains common but more variable than retinal disease or polydactyly, scoped to true BBS.
ORPHA:110 SUPPORT Other
"HP:0012622 | Chronic kidney disease | Frequent (79-30%)"
Orphanet classifies chronic kidney disease as frequent in BBS, supporting the clinical importance of renal involvement.
Limbs 2
Postaxial polydactyly FREQUENT Postaxial polydactyly HP:0100259
Show evidence (3 references)
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients ... Retinal dystrophy was the most common feature (94.1%), followed by polydactyly (88.0%), obesity (68.0%), and renal anomalies (52.0%)."
Molecularly confirmed BBS cohort (subject made explicit): polydactyly at 88% supports the frequent band in true BBS.
PMID:30614526 SUPPORT Human Clinical
"We report here the largest cohort of BBS fetuses to better characterize the antenatal presentation ... postaxial polydactyly (82%) and renal cysts (78%) were the most prevalent symptoms."
Independent support for frequent postaxial polydactyly; the subject is made explicit as a molecularly confirmed antenatal (fetal) BBS cohort, whose ascertainment differs from postnatal clinical series.
ORPHA:110 SUPPORT Other
"HP:0100259 | Postaxial polydactyly | Frequent (79-30%)"
Orphanet classifies postaxial polydactyly as frequent (79-30%) in Bardet-Biedl syndrome.
Brachydactyly FREQUENT Brachydactyly HP:0001156
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0001156 | Brachydactyly | Frequent (79-30%)"
Orphanet classifies brachydactyly as frequent (79-30%) in Bardet-Biedl syndrome.
Metabolism 1
Hypertriglyceridemia FREQUENT Hypertriglyceridemia HP:0002155
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0002155 | Hypertriglyceridemia | Frequent (79-30%)"
Orphanet classifies hypertriglyceridemia as frequent (79-30%) in Bardet-Biedl syndrome.
Nervous System 2
Hyperphagia Polyphagia HP:0002591
Show evidence (1 reference)
PMID:23776152 SUPPORT Human Clinical
"Total hyperphagia questionnaire score was higher in BBS than controls (27.6 ± 9.0 vs. 19.1 ± 7.9, P = 0.005)."
This controlled study shows that hyperphagic symptoms are increased in BBS relative to BMI-matched controls.
Neurodevelopmental delay VERY_FREQUENT Neurodevelopmental delay HP:0012758
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0012758 | Neurodevelopmental delay | Very frequent (99-80%)"
Orphanet classifies neurodevelopmental delay as very frequent (99-80%) in Bardet-Biedl syndrome.
Growth 1
Obesity VERY_FREQUENT Obesity HP:0001513
Show evidence (3 references)
PMID:32700463 SUPPORT Human Clinical
"BBS is typified by obesity in adulthood ... most individuals with BBS experience rapid weight gain in early childhood, with high rates of overweight/obesity sustained through adolescence."
Registry-based study of BBS patients: obesity is age-dependent, typifying adulthood (supporting the very frequent band) while building from early childhood. The subject is explicitly BBS, not the broader BBSome-opathy spectrum.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients ... obesity (68.0%)"
In this molecularly confirmed BBS cohort obesity was recorded in 68%; the figure is lower than the adult-typified very frequent band because the cohort is pediatric-inclusive, illustrating the cohort-dependence of the frequency. Subject is confirmed BBS.
ORPHA:110 SUPPORT Other
"HP:0001513 | Obesity | Very frequent (99-80%)"
Orphanet classifies obesity as very frequent (99-80%) in Bardet-Biedl syndrome.
Other 1
Learning disability FREQUENT Specific learning disability HP:0001328
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"HP:0001328 | Specific learning disability | Frequent (79-30%)"
Orphanet classifies specific learning disability as frequent (79-30%) in Bardet-Biedl syndrome.
🧬

Genetic Associations

26
BBS1 (Pathogenic biallelic variants)
Gene: BBS1 hgnc:966
Show evidence (3 references)
PMID:28143435 SUPPORT Human Clinical
"The most common mutated gene was BBS1 followed by BBS10."
This Italian cohort identifies BBS1 as the most common gene in that series.
PMID:35886001 SUPPORT Human Clinical
"The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5 (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles)."
This independent cohort confirms BBS1 as one of the two dominant genotype groups in contemporary clinical series.
ORPHA:110 SUPPORT Other
"BBS1 | Bardet-Biedl syndrome 1 | hgnc:966 | Disease-causing germline mutation(s) in"
Orphanet lists BBS1 as a disease-causing gene for Bardet-Biedl syndrome.
BBS10 (Pathogenic biallelic variants)
Gene: BBS10 hgnc:26291
Show evidence (4 references)
PMID:35886001 SUPPORT Human Clinical
"The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5 (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles)."
This German cohort identifies BBS10 as the most common genotype in that series.
PMID:28143435 SUPPORT Human Clinical
"BBS10 was associated with the worse outcome in terms of the renal, ocular and audiovestibular phenotypes."
This cohort supports recording BBS10 as a genotype associated with more severe multisystem disease.
PMID:21209035 SUPPORT Human Clinical
"BBS1 (27%) and BBS10 (30%) mutations were the most prevalent."
This metabolic cohort independently confirms BBS10 as one of the most prevalent genotypes.
+ 1 more reference
BBS2 (Pathogenic biallelic variants)
Gene: BBS2 hgnc:967
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBS2 | Bardet-Biedl syndrome 2 | hgnc:967 | Disease-causing germline mutation(s) in"
Orphanet lists BBS2 as a disease-causing gene for Bardet-Biedl syndrome.
ARL6 (Pathogenic biallelic variants)
Gene: ARL6 hgnc:13210
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"ARL6 | ARF like GTPase 6 | hgnc:13210 | Disease-causing germline mutation(s) in"
Orphanet lists ARL6 as a disease-causing gene for Bardet-Biedl syndrome.
MKKS (Pathogenic biallelic variants)
Gene: MKKS hgnc:7108
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"MKKS | MKKS centrosomal shuttling protein | hgnc:7108 | Disease-causing germline mutation(s) in"
Orphanet lists MKKS as a disease-causing gene for Bardet-Biedl syndrome.
CEP290 (Pathogenic biallelic variants)
Gene: CEP290 hgnc:29021
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"CEP290 | centrosomal protein 290 | hgnc:29021 | Disease-causing germline mutation(s) in"
Orphanet lists CEP290 as a disease-causing gene for Bardet-Biedl syndrome.
TTC8 (Pathogenic biallelic variants)
Gene: TTC8 hgnc:20087
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"TTC8 | tetratricopeptide repeat domain 8 | hgnc:20087 | Disease-causing germline mutation(s) in"
Orphanet lists TTC8 as a disease-causing gene for Bardet-Biedl syndrome.
BBS4 (Pathogenic biallelic variants)
Gene: BBS4 hgnc:969
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBS4 | Bardet-Biedl syndrome 4 | hgnc:969 | Disease-causing germline mutation(s) in"
Orphanet lists BBS4 as a disease-causing gene for Bardet-Biedl syndrome.
BBS5 (Pathogenic biallelic variants)
Gene: BBS5 hgnc:970
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBS5 | Bardet-Biedl syndrome 5 | hgnc:970 | Disease-causing germline mutation(s) in"
Orphanet lists BBS5 as a disease-causing gene for Bardet-Biedl syndrome.
BBS7 (Pathogenic biallelic variants)
Gene: BBS7 hgnc:18758
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBS7 | Bardet-Biedl syndrome 7 | hgnc:18758 | Disease-causing germline mutation(s) in"
Orphanet lists BBS7 as a disease-causing gene for Bardet-Biedl syndrome.
BBS9 (Pathogenic biallelic variants)
Gene: BBS9 hgnc:30000
Show evidence (3 references)
ORPHA:110 SUPPORT Other
"BBS9 | Bardet-Biedl syndrome 9 | hgnc:30000 | Disease-causing germline mutation(s) in"
Orphanet lists BBS9 as a disease-causing gene for Bardet-Biedl syndrome.
PMID:41219488 SUPPORT Human Clinical
"Biallelic pathogenic variants were identified in all patients, including three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in four patients, including two siblings."
This recent cohort identifies novel BBS9 variants among clinically confirmed BBS patients.
PMID:30614526 SUPPORT Human Clinical
"Molecular diagnosis during pregnancies remains a timely challenge for this heterogeneous disease (22 known genes)."
This large molecularly confirmed series supports broad genetic heterogeneity within classic BBS, of which BBS9 is one established locus.
BBIP1 (Pathogenic biallelic variants)
Gene: BBIP1 hgnc:28093
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBIP1 | BBSome interacting protein 1 | hgnc:28093 | Disease-causing germline mutation(s) in"
Orphanet lists BBIP1 as a disease-causing gene for Bardet-Biedl syndrome.
BBS12 (Pathogenic biallelic variants)
Gene: BBS12 hgnc:26648
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"BBS12 | Bardet-Biedl syndrome 12 | hgnc:26648 | Disease-causing germline mutation(s) in"
Orphanet lists BBS12 as a disease-causing gene for Bardet-Biedl syndrome.
LZTFL1 (Pathogenic biallelic variants)
Gene: LZTFL1 hgnc:6741
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"LZTFL1 | leucine zipper transcription factor like 1 | hgnc:6741 | Disease-causing germline mutation(s) in"
Orphanet lists LZTFL1 as a disease-causing gene for Bardet-Biedl syndrome.
TRIM32 (Pathogenic biallelic variants)
Gene: TRIM32 hgnc:16380
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"TRIM32 | tripartite motif containing 32 | hgnc:16380 | Disease-causing germline mutation(s) in"
Orphanet lists TRIM32 as a disease-causing gene for Bardet-Biedl syndrome.
WDPCP (Pathogenic biallelic variants)
Gene: WDPCP hgnc:28027
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"WDPCP | WD repeat containing planar cell polarity effector | hgnc:28027 | Disease-causing germline mutation(s) in"
Orphanet lists WDPCP as a disease-causing gene for Bardet-Biedl syndrome.
IFT27 (Pathogenic biallelic variants)
Gene: IFT27 hgnc:18626
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"IFT27 | intraflagellar transport 27 | hgnc:18626 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists IFT27 as a disease-causing gene for Bardet-Biedl syndrome.
IFT172 (Pathogenic biallelic variants)
Gene: IFT172 hgnc:30391
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"IFT172 | intraflagellar transport 172 | hgnc:30391 | Disease-causing germline mutation(s) in"
Orphanet lists IFT172 as a disease-causing gene for Bardet-Biedl syndrome.
IFT74 (Pathogenic biallelic variants)
Gene: IFT74 hgnc:21424
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"IFT74 | intraflagellar transport 74 | hgnc:21424 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists IFT74 as a disease-causing gene for Bardet-Biedl syndrome.
MKS1 (Pathogenic biallelic variants)
Gene: MKS1 hgnc:7121
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"MKS1 | MKS transition zone complex subunit 1 | hgnc:7121 | Disease-causing germline mutation(s) in"
Orphanet lists MKS1 as a disease-causing gene for Bardet-Biedl syndrome.
SDCCAG8 (Pathogenic biallelic variants)
Gene: SDCCAG8 hgnc:10671
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"SDCCAG8 | SHH signaling and ciliogenesis regulator SDCCAG8 | hgnc:10671 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists SDCCAG8 as a disease-causing gene for Bardet-Biedl syndrome.
NPHP1 (Pathogenic biallelic variants)
Gene: NPHP1 hgnc:7905
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"NPHP1 | nephrocystin 1 | hgnc:7905 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists NPHP1 as a disease-causing gene for Bardet-Biedl syndrome.
CEP19 (Pathogenic biallelic variants)
Gene: CEP19 hgnc:28209
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"CEP19 | centrosomal protein 19 | hgnc:28209 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists CEP19 as a disease-causing gene for Bardet-Biedl syndrome.
CFAP418 (Pathogenic biallelic variants)
Gene: CFAP418 hgnc:27232
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"CFAP418 | cilia and flagella associated protein 418 | hgnc:27232 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists CFAP418 as a disease-causing gene for Bardet-Biedl syndrome.
SCAPER (Pathogenic biallelic variants)
Gene: SCAPER hgnc:13081
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"SCAPER | S-phase cyclin A associated protein in the ER | hgnc:13081 | Disease-causing germline mutation(s) (loss of function) in"
Orphanet lists SCAPER as a disease-causing gene for Bardet-Biedl syndrome.
SCLT1 (Pathogenic biallelic variants)
Gene: SCLT1 hgnc:26406
Show evidence (1 reference)
ORPHA:110 SUPPORT Other
"SCLT1 | sodium channel and clathrin linker 1 | hgnc:26406 | Disease-causing germline mutation(s) in"
Orphanet lists SCLT1 as a disease-causing gene for Bardet-Biedl syndrome.
💊

Medical Actions

2
Setmelanotide
Action: targeted therapy Ontology label: Targeted Therapy NCIT:C93352
Agent: setmelanotide NCIT:C152349
MC4R agonist pharmacotherapy that bypasses upstream ciliopathy-related satiety-pathway dysfunction and reduces bodyweight in Bardet-Biedl syndrome.
Target Phenotypes: obesity HP:0001513
Show evidence (2 references)
PMID:36356613 SUPPORT Human Clinical
"32·3% (95% CI 16·7 to 51·4; p=0·0006) of patients aged 12 years or older with Bardet-Biedl syndrome reached at least a 10% reduction in bodyweight after 52 weeks of setmelanotide."
This phase 3 trial provides direct evidence that MC4R agonism can reduce bodyweight in BBS.
PMID:36356613 SUPPORT Human Clinical
"These results support the use of setmelanotide and provided the necessary evidence for approval of this drug as the first treatment for obesity in patients with Bardet-Biedl syndrome."
The trial interpretation explicitly supports setmelanotide as the approved obesity-directed treatment for BBS.
Kidney transplantation
Action: organ transplantation MAXO:0010039
Organ transplantation is a viable treatment option for the subset of BBS patients who progress to end-stage renal disease.
Show evidence (1 reference)
PMID:27245600 SUPPORT Human Clinical
"Although the frequency of obesity and other manifestations of the metabolic syndrome warrant meticulous management in this high-risk population, favorable long-term outcomes suggest that renal transplantation is a viable option for patients with BBS and ESRD."
This registry-based transplant study supports kidney transplantation for the ESRD subset of BBS.
🔬

Biochemical Markers

1
Leptin (Increased)
Show evidence (1 reference)
PMID:21209035 SUPPORT Human Clinical
"Patients with BBS had higher leptin than expected for their degree of adiposity, consistent with the notion that ciliopathy-induced leptin signaling dysfunction is associated with leptin resistance."
This metabolic study supports hyperleptinemia as a human biochemical correlate of leptin resistance in BBS.
{ }

Source YAML

click to show 
name: Bardet-Biedl syndrome
creation_date: "2025-12-04T16:57:31Z"
updated_date: "2026-04-28T12:00:00Z"
category: Mendelian
description: >-
  Bardet-Biedl syndrome is a genetically heterogeneous autosomal recessive
  ciliopathy caused by biallelic pathogenic variants in established BBS genes
  encoding the BBSome, its chaperonin-like assembly machinery, and closely
  related ciliary trafficking proteins. The core disease logic is failure of
  primary-cilium cargo trafficking, producing retinal degeneration, early-onset
  obesity with hyperphagia, postaxial polydactyly, and structurally and
  functionally abnormal kidneys.
disease_term:
  preferred_term: Bardet-Biedl syndrome
  term:
    id: MONDO:0015229
    label: Bardet-Biedl syndrome
classifications:
  harrisons_chapter:
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
  mechanistic_category:
  - classification_value: ciliopathy
parents:
- Syndromic Obesity
- Ciliopathy
synonyms:
- BBS
notes: >-
  This entry is framed at the classic syndrome level rather than split into a
  large number of gene-specific diseases. Gene-specific differences such as
  relatively milder BBS1 disease and more severe BBS10 renal and ocular disease
  are recorded as genotype-phenotype observations, while noncanonical
  "BBS-like" phenocopies are not merged automatically into this file.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Classic Bardet-Biedl syndrome is an autosomal recessive syndromic
    ciliopathy.
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a
      wide spectrum of clinical features including obesity, retinitis pigmentosa,
      polydactyly, mental retardation, hypogonadism, and renal abnormalities.
    explanation: >-
      This cohort abstract explicitly states autosomal recessive inheritance for
      classic BBS.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Autosomal recessive"
    explanation: >-
      Orphanet classifies Bardet-Biedl syndrome as autosomal recessive
      inheritance.
- name: Oligogenic inheritance
  inheritance_term:
    preferred_term: Oligogenic inheritance
  description: >-
    A subset of BBS families show evidence of oligogenic (triallelic)
    inheritance, where variants at a second BBS locus are required to
    manifest the phenotype.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "Oligogenic"
    explanation: >-
      Orphanet lists oligogenic as an additional inheritance pattern for
      Bardet-Biedl syndrome.
  - reference: PMID:11567139
    reference_title: "Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We therefore propose that BBS may not be a single-gene recessive disease
      but a complex trait requiring three mutant alleles to manifest the
      phenotype.
    explanation: >-
      The landmark Katsanis et al. 2001 paper provides direct evidence for
      triallelic/oligogenic inheritance in BBS families.
prevalence:
- population: European populations
  percentage: 1 in 160,000
  notes: >-
    Founder populations can be much more common; the same epidemiologic abstract
    cites prevalence as high as 1 in 13,000 in Kuwaiti Bedouins and estimated
    minimum prevalence of approximately 1 in 156,000 in Tunisia.
  evidence:
  - reference: PMID:22109794
    reference_title: "Prevalence of Bardet-Biedl syndrome in Tunisia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence of BBS has been estimated in different populations, ranging
      from 1 in 160,000 in European populations to 1 in 13,000 in Bedouins from
      Kuwait.
    explanation: >-
      This epidemiologic study provides a commonly cited prevalence range for
      BBS, including the European estimate used here.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "1-9 / 1 000 000 | Europe | Prevalence at birth"
    explanation: >-
      Orphanet epidemiology data supports the 1 in 160,000 European birth
      prevalence estimate.
- population: United States
  percentage: 1 in 100,000
  notes: >-
    Aggregate population frequency estimate for a general North American
    outbred population descended primarily from Europeans.
  evidence:
  - reference: PMID:20949666
    reference_title: "Recurrence risks for Bardet-Biedl syndrome: Implications of locus heterogeneity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      an aggregate population frequency of 1/100,000 for the phenotype
    explanation: >-
      This locus-heterogeneity study uses 1/100,000 as the aggregate US
      population frequency for BBS.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "1-9 / 100 000 | United States | Point prevalence"
    explanation: >-
      Orphanet epidemiology lists US point prevalence in the 1-9 per 100,000
      range, consistent with the 1/100,000 estimate.
- population: Specific populations (Bedouin, Newfoundland)
  percentage: 1 in 13,000 to 1 in 17,000
  notes: >-
    Founder populations with high consanguinity rates show much higher
    prevalence.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "1-9 / 100 000 | Specific population | Point prevalence"
    explanation: >-
      Orphanet epidemiology lists prevalence in specific populations as 1-9
      per 100,000, reflecting founder-effect populations.
genetic:
- name: BBS1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  frequency: one of the most prevalent BBS genes
  notes: >-
    BBS1 is a recurrent cause of classic BBS; the common p.M390R allele is
    frequent in multiple cohorts and BBS1 disease can be milder than BBS10 in
    some series.
  evidence:
  - reference: PMID:28143435
    reference_title: "Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common mutated gene was BBS1 followed by BBS10.
    explanation: >-
      This Italian cohort identifies BBS1 as the most common gene in that
      series.
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and
      by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5
      (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles).
    explanation: >-
      This independent cohort confirms BBS1 as one of the two dominant genotype
      groups in contemporary clinical series.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS1 | Bardet-Biedl syndrome 1 | hgnc:966 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS1 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS10
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS10
    term:
      id: hgnc:26291
      label: BBS10
  frequency: one of the most prevalent BBS genes
  notes: >-
    BBS10 is a common cause of BBS and is associated with more severe renal and
    ocular disease in some human cohorts.
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The most common associated genes were BBS10 (32.8%) and BBS1 (24.6%), and
      by far the most commonly observed variants were BBS10 c.271dup;p.C91Lfs*5
      (21 alleles) and BBS1 c.1169T>G;p.M390R (18 alleles).
    explanation: >-
      This German cohort identifies BBS10 as the most common genotype in that
      series.
  - reference: PMID:28143435
    reference_title: "Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS10 was associated with the worse outcome in terms of the renal, ocular
      and audiovestibular phenotypes.
    explanation: >-
      This cohort supports recording BBS10 as a genotype associated with more
      severe multisystem disease.
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS1 (27%) and BBS10 (30%) mutations were the most prevalent.
    explanation: >-
      This metabolic cohort independently confirms BBS10 as one of the most
      prevalent genotypes.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS10 | Bardet-Biedl syndrome 10 | hgnc:26291 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS10 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS2
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  notes: >-
    BBS2 encodes a core BBSome subunit and is an established cause of classic
    BBS.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS2 | Bardet-Biedl syndrome 2 | hgnc:967 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS2 as a disease-causing gene for Bardet-Biedl syndrome.
- name: ARL6
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  notes: >-
    ARL6 (also known as BBS3) is an ARF-like GTPase involved in ciliary
    membrane trafficking.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "ARL6 | ARF like GTPase 6 | hgnc:13210 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists ARL6 as a disease-causing gene for Bardet-Biedl syndrome.
- name: MKKS
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: MKKS
    term:
      id: hgnc:7108
      label: MKKS
  notes: >-
    MKKS (BBS6) encodes a chaperonin-like protein required for BBSome assembly.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "MKKS | MKKS centrosomal shuttling protein | hgnc:7108 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists MKKS as a disease-causing gene for Bardet-Biedl syndrome.
- name: CEP290
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: CEP290
    term:
      id: hgnc:29021
      label: CEP290
  notes: >-
    CEP290 encodes a centrosomal protein involved in ciliary transition zone
    function; pathogenic variants can cause BBS and other ciliopathies.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "CEP290 | centrosomal protein 290 | hgnc:29021 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists CEP290 as a disease-causing gene for Bardet-Biedl syndrome.
- name: TTC8
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: TTC8
    term:
      id: hgnc:20087
      label: TTC8
  notes: >-
    TTC8 (BBS8) encodes a core BBSome subunit.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TTC8 | tetratricopeptide repeat domain 8 | hgnc:20087 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists TTC8 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS4
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS4
    term:
      id: hgnc:969
      label: BBS4
  notes: >-
    BBS4 encodes a core BBSome subunit that links the complex to the
    pericentriolar material and microtubule transport.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS4 | Bardet-Biedl syndrome 4 | hgnc:969 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS4 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS5
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS5
    term:
      id: hgnc:970
      label: BBS5
  notes: >-
    BBS5 encodes a core BBSome subunit with pleckstrin-homology domains that
    bind membrane phosphoinositides.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS5 | Bardet-Biedl syndrome 5 | hgnc:970 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS5 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS7
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS7
    term:
      id: hgnc:18758
      label: BBS7
  notes: >-
    BBS7 encodes a core BBSome subunit and also interacts with the
    BBS-chaperonin complex during BBSome assembly.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS7 | Bardet-Biedl syndrome 7 | hgnc:18758 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS7 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS9
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS9
    term:
      id: hgnc:30000
      label: BBS9
  notes: >-
    BBS9 (PTHB1) encodes a core BBSome subunit and is a recurrent cause of
    classic BBS in molecularly confirmed cohorts.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS9 | Bardet-Biedl syndrome 9 | hgnc:30000 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS9 as a disease-causing gene for Bardet-Biedl syndrome.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients, including
      three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in
      four patients, including two siblings.
    explanation: >-
      This recent cohort identifies novel BBS9 variants among clinically
      confirmed BBS patients.
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular diagnosis during pregnancies remains a timely challenge for this
      heterogeneous disease (22 known genes).
    explanation: >-
      This large molecularly confirmed series supports broad genetic
      heterogeneity within classic BBS, of which BBS9 is one established locus.
- name: BBIP1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBIP1
    term:
      id: hgnc:28093
      label: BBIP1
  notes: >-
    BBIP1 (BBS18) encodes the smallest BBSome subunit, required for BBSome
    integrity and cytoplasmic microtubule stabilization.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBIP1 | BBSome interacting protein 1 | hgnc:28093 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBIP1 as a disease-causing gene for Bardet-Biedl syndrome.
- name: BBS12
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: BBS12
    term:
      id: hgnc:26648
      label: BBS12
  notes: >-
    BBS12 encodes a type II chaperonin-like protein that, with MKKS/BBS6 and
    BBS10, forms the BBS-chaperonin complex required for BBSome assembly.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "BBS12 | Bardet-Biedl syndrome 12 | hgnc:26648 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists BBS12 as a disease-causing gene for Bardet-Biedl syndrome.
- name: LZTFL1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: LZTFL1
    term:
      id: hgnc:6741
      label: LZTFL1
  notes: >-
    LZTFL1 (BBS17) is a negative regulator of BBSome ciliary trafficking and
    Hedgehog/Smoothened signaling.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "LZTFL1 | leucine zipper transcription factor like 1 | hgnc:6741 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists LZTFL1 as a disease-causing gene for Bardet-Biedl syndrome.
- name: TRIM32
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: TRIM32
    term:
      id: hgnc:16380
      label: TRIM32
  notes: >-
    TRIM32 (BBS11) encodes an E3 ubiquitin ligase; the same gene is also
    associated with limb-girdle muscular dystrophy.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "TRIM32 | tripartite motif containing 32 | hgnc:16380 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists TRIM32 as a disease-causing gene for Bardet-Biedl syndrome.
- name: WDPCP
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: WDPCP
    term:
      id: hgnc:28027
      label: WDPCP
  notes: >-
    WDPCP (BBS15) is a planar cell polarity effector required for ciliogenesis
    and collective cell movement.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "WDPCP | WD repeat containing planar cell polarity effector | hgnc:28027 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists WDPCP as a disease-causing gene for Bardet-Biedl syndrome.
- name: IFT27
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: IFT27
    term:
      id: hgnc:18626
      label: IFT27
  notes: >-
    IFT27 (BBS19) is a Rab-like GTPase of the IFT-B complex required for BBSome
    recycling and exit of signaling receptors from cilia.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "IFT27 | intraflagellar transport 27 | hgnc:18626 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists IFT27 as a disease-causing gene for Bardet-Biedl syndrome.
- name: IFT172
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: IFT172
    term:
      id: hgnc:30391
      label: IFT172
  notes: >-
    IFT172 (BBS20) is an IFT-B complex component required for anterograde
    intraflagellar transport and ciliary assembly.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "IFT172 | intraflagellar transport 172 | hgnc:30391 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists IFT172 as a disease-causing gene for Bardet-Biedl syndrome.
- name: IFT74
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: IFT74
    term:
      id: hgnc:21424
      label: IFT74
  notes: >-
    IFT74 (BBS22) is an IFT-B core component; biallelic loss-of-function
    variants cause a BBS phenotype.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "IFT74 | intraflagellar transport 74 | hgnc:21424 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists IFT74 as a disease-causing gene for Bardet-Biedl syndrome.
- name: MKS1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: MKS1
    term:
      id: hgnc:7121
      label: MKS1
  notes: >-
    MKS1 (BBS13) encodes a transition-zone (MKS module) protein; variants can
    cause BBS as well as Meckel and Joubert syndromes.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "MKS1 | MKS transition zone complex subunit 1 | hgnc:7121 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists MKS1 as a disease-causing gene for Bardet-Biedl syndrome.
- name: SDCCAG8
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: SDCCAG8
    term:
      id: hgnc:10671
      label: SDCCAG8
  notes: >-
    SDCCAG8 (BBS16) encodes a centrosomal/transition-zone protein associated
    with renal-retinal ciliopathy and BBS.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "SDCCAG8 | SHH signaling and ciliogenesis regulator SDCCAG8 | hgnc:10671 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists SDCCAG8 as a disease-causing gene for Bardet-Biedl syndrome.
- name: NPHP1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: NPHP1
    term:
      id: hgnc:7905
      label: NPHP1
  notes: >-
    NPHP1 (nephrocystin-1) encodes a transition-zone protein; biallelic loss
    can produce a BBS-like nephronophthisis-related ciliopathy.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "NPHP1 | nephrocystin 1 | hgnc:7905 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists NPHP1 as a disease-causing gene for Bardet-Biedl syndrome.
- name: CEP19
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: CEP19
    term:
      id: hgnc:28209
      label: CEP19
  notes: >-
    CEP19 encodes a centrosomal/ciliary protein; loss-of-function variants
    cause a morbid-obesity BBS-like ciliopathy.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "CEP19 | centrosomal protein 19 | hgnc:28209 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists CEP19 as a disease-causing gene for Bardet-Biedl syndrome.
- name: CFAP418
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: CFAP418
    term:
      id: hgnc:27232
      label: CFAP418
  notes: >-
    CFAP418 (C8orf37, BBS21) encodes a ciliary protein associated with retinal
    dystrophy and BBS.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "CFAP418 | cilia and flagella associated protein 418 | hgnc:27232 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists CFAP418 as a disease-causing gene for Bardet-Biedl syndrome.
- name: SCAPER
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: SCAPER
    term:
      id: hgnc:13081
      label: SCAPER
  notes: >-
    SCAPER loss-of-function variants cause a BBS-like syndrome combining
    retinitis pigmentosa with intellectual disability.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "SCAPER | S-phase cyclin A associated protein in the ER | hgnc:13081 | Disease-causing germline mutation(s) (loss of function) in"
    explanation: >-
      Orphanet lists SCAPER as a disease-causing gene for Bardet-Biedl syndrome.
- name: SCLT1
  association: Pathogenic biallelic variants
  gene_term:
    preferred_term: SCLT1
    term:
      id: hgnc:26406
      label: SCLT1
  notes: >-
    SCLT1 (sodium channel and clathrin linker 1) encodes a distal-appendage
    protein required for ciliogenesis and is associated with BBS.
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "SCLT1 | sodium channel and clathrin linker 1 | hgnc:26406 | Disease-causing germline mutation(s) in"
    explanation: >-
      Orphanet lists SCLT1 as a disease-causing gene for Bardet-Biedl syndrome.
pathophysiology:
- name: Pathogenic BBS gene defects
  description: >-
    Biallelic pathogenic variants in any of the >20 established BBS genes
    initiate classic Bardet-Biedl syndrome. The genes partition into four
    functional modules that converge on a common ciliary trafficking defect:
    BBSome subunits, the BBS-chaperonin assembly complex, the ARL6/IFT
    membrane-recruitment and transport machinery, and transition-zone/basal-body
    gatekeeping proteins.
  genes:
  - preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  - preferred_term: BBS10
    term:
      id: hgnc:26291
      label: BBS10
  - preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  - preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  - preferred_term: MKKS
    term:
      id: hgnc:7108
      label: MKKS
  - preferred_term: CEP290
    term:
      id: hgnc:29021
      label: CEP290
  evidence:
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Molecular diagnosis during pregnancies remains a timely challenge for this
      heterogeneous disease (22 known genes).
    explanation: >-
      This large prenatal molecular series supports disease initiation by
      biallelic pathogenic variants across many established BBS genes.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients, including
      three novel variants in the ARL6/BBS3, BBS9, and BBS10 genes, observed in
      four patients, including two siblings.
    explanation: >-
      This recent cohort confirms that clinically diagnosed BBS is anchored by
      biallelic pathogenic variants in established BBS genes.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "A rare genetic multisystem disorder characterized by the variable association of retinal dystrophy, obesity, polydactyly, genitourinary and kidney anomalies, learning disability and hypogonadism"
    explanation: >-
      Orphanet definition confirms BBS as a rare genetic multisystem disorder
      with the cardinal features anchored by pathogenic gene defects.
  downstream:
  - target: BBSome subunit deficiency
    description: Variants in BBSome subunit genes destabilize the eight-subunit core complex.
  - target: BBS-chaperonin assembly defect
    description: Variants in the chaperonin-like BBS genes impair assembly of the BBSome.
  - target: ARL6/IFT BBSome membrane recruitment and transport defect
    description: Variants in ARL6, LZTFL1, and IFT genes disrupt BBSome membrane recruitment and intraflagellar transport.
  - target: Ciliary transition zone and basal body dysfunction
    description: Variants in transition-zone and basal-body genes compromise the ciliary gate that the BBSome must traverse.
- name: BBSome subunit deficiency
  conforms_to: "bbsome_trafficking#BBSome Subunit Deficiency"
  description: >-
    Pathogenic variants in core BBSome subunit genes destabilize the obligate
    eight-subunit BBSome, the membrane-coat complex that escorts signaling
    cargo out of cilia.
  genes:
  - preferred_term: BBS1
    term:
      id: hgnc:966
      label: BBS1
  - preferred_term: BBS2
    term:
      id: hgnc:967
      label: BBS2
  - preferred_term: BBS4
    term:
      id: hgnc:969
      label: BBS4
  - preferred_term: BBS5
    term:
      id: hgnc:970
      label: BBS5
  - preferred_term: BBS7
    term:
      id: hgnc:18758
      label: BBS7
  - preferred_term: TTC8
    term:
      id: hgnc:20087
      label: TTC8
  - preferred_term: BBS9
    term:
      id: hgnc:30000
      label: BBS9
  - preferred_term: BBIP1
    term:
      id: hgnc:28093
      label: BBIP1
  cellular_components:
  - preferred_term: BBSome
    term:
      id: GO:0034464
      label: BBSome
  evidence:
  - reference: PMID:22072986
    reference_title: "A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We also show that all BBSome subunits and BBS3 (also known as ARL6) are
      required for BBSome ciliary entry
    explanation: >-
      This study demonstrates that the full set of BBSome subunits is required
      for ciliary entry, so loss of any subunit gene compromises the complex.
  downstream:
  - target: Defective BBSome assembly
    description: Loss of a subunit prevents formation of a stable, functional BBSome.
- name: BBS-chaperonin assembly defect
  conforms_to: "bbsome_trafficking#BBS Chaperonin Assembly Defect"
  description: >-
    The chaperonin-like BBS proteins MKKS/BBS6, BBS10, and BBS12 form a
    BBS-chaperonin complex with CCT/TRiC that is required for ordered BBSome
    assembly; their loss prevents the BBSome from being built.
  genes:
  - preferred_term: MKKS
    term:
      id: hgnc:7108
      label: MKKS
  - preferred_term: BBS10
    term:
      id: hgnc:26291
      label: BBS10
  - preferred_term: BBS12
    term:
      id: hgnc:26648
      label: BBS12
  evidence:
  - reference: PMID:22500027
    reference_title: "Intrinsic protein-protein interaction-mediated and chaperonin-assisted sequential assembly of stable bardet-biedl syndrome protein complex, the BBSome."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Three additional BBS genes (BBS6, BBS10, and BBS12) have homology to type
      II chaperonins and interact with CCT/TRiC proteins and BBS7 to form a
      complex termed the BBS-chaperonin complex. This complex is required for
      BBSome assembly.
    explanation: >-
      This mechanistic study directly supports chaperonin-dependent failure of
      BBSome assembly as an early causal step in BBS.
  - reference: PMID:20080638
    reference_title: "BBS6, BBS10, and BBS12 form a complex with CCT/TRiC family chaperonins and mediate BBSome assembly."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our data demonstrate that BBS6, BBS10, and BBS12 are necessary for BBSome
      assembly, and that impaired BBSome assembly contributes to the etiology of
      BBS phenotypes associated with the loss of function of these three BBS
      genes.
    explanation: >-
      This complementary paper independently supports BBSome assembly failure as
      a proximal disease mechanism.
  downstream:
  - target: Defective BBSome assembly
    description: Without the BBS-chaperonin complex, subunits cannot be folded and assembled into the BBSome.
- name: Defective BBSome assembly
  conforms_to: "bbsome_trafficking#Defective BBSome Assembly"
  description: >-
    Loss of core subunits or of the chaperonin assembly machinery prevents
    formation of the obligate BBSome, the ciliary membrane-coat trafficking
    complex central to BBS biology.
  cellular_components:
  - preferred_term: BBSome
    term:
      id: GO:0034464
      label: BBSome
  - preferred_term: primary cilium
    term:
      id: GO:0005929
      label: cilium
  evidence:
  - reference: PMID:31303482
    reference_title: "The Molecular Architecture of Native BBSome Obtained by an Integrated Structural Approach."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We find that BBSome subunits have a very high degree of interconnectivity,
      explaining the obligate nature of the complex.
    explanation: >-
      The native-BBSome structure shows the subunits are highly interconnected
      and obligate, so loss of subunit or assembly factors disrupts the complex.
  downstream:
  - target: Ciliary membrane protein trafficking defect
    description: An incompletely assembled BBSome fails to move selected cargos correctly through the ciliary compartment.
- name: ARL6/IFT BBSome membrane recruitment and transport defect
  conforms_to: "bbsome_trafficking#BBSome Membrane Recruitment and Retrograde IFT Coupling"
  description: >-
    The ARF-like GTPase ARL6/BBS3 recruits the autoinhibited BBSome to the
    ciliary membrane, where it couples to intraflagellar transport (IFT) trains;
    LZTFL1 regulates this trafficking. Loss of ARL6, LZTFL1, or IFT subunits
    blocks BBSome-dependent cargo movement even when the BBSome is intact.
  genes:
  - preferred_term: ARL6
    term:
      id: hgnc:13210
      label: ARL6
  - preferred_term: LZTFL1
    term:
      id: hgnc:6741
      label: LZTFL1
  - preferred_term: IFT27
    term:
      id: hgnc:18626
      label: IFT27
  - preferred_term: IFT74
    term:
      id: hgnc:21424
      label: IFT74
  - preferred_term: IFT172
    term:
      id: hgnc:30391
      label: IFT172
  cellular_components:
  - preferred_term: primary cilium
    term:
      id: GO:0005929
      label: cilium
  biological_processes:
  - preferred_term: intraciliary transport
    term:
      id: GO:0042073
      label: intraciliary transport
  evidence:
  - reference: PMID:31303482
    reference_title: "The Molecular Architecture of Native BBSome Obtained by an Integrated Structural Approach."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      the BBSome exists in an autoinhibited state in solution and must thus
      undergo a conformational change upon recruitment to membranes by the small
      GTPase ARL6/BBS3
    explanation: >-
      The structural study shows ARL6/BBS3 is required to recruit and activate
      the BBSome at the membrane, so ARL6 loss blocks BBSome function.
  - reference: PMID:33587040
    reference_title: "Bardet-Biedl syndrome 3 protein promotes ciliary exit of the signaling protein phospholipase D via the BBSome."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      GTP-bound BBS3 binds and recruits BBSomes to the ciliary membrane for
      interacting with PLD, thus making the PLD-laden BBSomes available to load
      onto retrograde IFT trains for ciliary exit.
    explanation: >-
      This in vivo study shows ARL6/BBS3 recruits the BBSome to the membrane and
      couples it to retrograde IFT for ciliary exit of signaling cargo.
  - reference: PMID:22072986
    reference_title: "A novel protein LZTFL1 regulates ciliary trafficking of the BBSome and Smoothened."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      LZTFL1), interacts with a BBS protein complex known as the BBSome and
      regulates ciliary trafficking of this complex
    explanation: >-
      LZTFL1 (BBS17) regulates BBSome ciliary trafficking, so its loss perturbs
      BBSome-dependent cargo movement.
  downstream:
  - target: Ciliary membrane protein trafficking defect
    description: Defective membrane recruitment and IFT coupling stall BBSome-dependent cargo transport.
- name: Ciliary transition zone and basal body dysfunction
  conforms_to: "ciliopathy_dysfunction#Basal Body and Transition Zone Dysfunction"
  description: >-
    Transition-zone and basal-body BBS genes maintain the ciliary diffusion
    barrier and protein gate that the BBSome traverses. Their loss disrupts
    ciliary protein composition and produces BBS-like multisystem disease.
  genes:
  - preferred_term: CEP290
    term:
      id: hgnc:29021
      label: CEP290
  - preferred_term: MKS1
    term:
      id: hgnc:7121
      label: MKS1
  - preferred_term: SDCCAG8
    term:
      id: hgnc:10671
      label: SDCCAG8
  - preferred_term: NPHP1
    term:
      id: hgnc:7905
      label: NPHP1
  - preferred_term: CEP19
    term:
      id: hgnc:28209
      label: CEP19
  - preferred_term: SCLT1
    term:
      id: hgnc:26406
      label: SCLT1
  cellular_components:
  - preferred_term: ciliary transition zone
    term:
      id: GO:0035869
      label: ciliary transition zone
  - preferred_term: ciliary basal body
    term:
      id: GO:0036064
      label: ciliary basal body
  biological_processes:
  - preferred_term: cilium assembly
    term:
      id: GO:0060271
      label: cilium assembly
    modifier: DECREASED
  - preferred_term: protein localization to cilium
    term:
      id: GO:0061512
      label: protein localization to cilium
    modifier: ABNORMAL
  evidence:
  - reference: PMID:24722439
    reference_title: "Renal-retinal ciliopathy gene Sdccag8 regulates DNA damage response signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      These mice exhibited early onset retinal degeneration that was associated
      with rhodopsin mislocalization in the photoreceptors and reduced cone cell
      numbers, and led to progressive loss of vision.
    explanation: >-
      Loss of the transition-zone/centrosomal gene SDCCAG8 mislocalizes
      rhodopsin and degenerates photoreceptors, linking ciliary-gate dysfunction
      to the BBS retinal phenotype.
  downstream:
  - target: Ciliary membrane protein trafficking defect
    description: A defective ciliary gate corrupts the ciliary protein composition the BBSome depends on.
- name: Ciliary membrane protein trafficking defect
  conforms_to: "bbsome_trafficking#BBSome-Dependent Ciliary Cargo Trafficking Failure"
  description: >-
    Failure of an intact, membrane-recruited BBSome traversing a competent
    ciliary gate disrupts trafficking of signaling proteins and other cargos
    into and within the ciliary compartment.
  cellular_components:
  - preferred_term: primary cilium
    term:
      id: GO:0005929
      label: cilium
  biological_processes:
  - preferred_term: protein localization to cilium
    term:
      id: GO:0061512
      label: protein localization to cilium
  - preferred_term: intraciliary transport
    term:
      id: GO:0042073
      label: intraciliary transport
  evidence:
  - reference: PMID:36699005
    reference_title: "Ciliary signaling proteins are mislocalized in the brains of Bardet-Biedl syndrome 1-null mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      GPCR ciliary localization is disrupted in neurons from mouse models of the
      ciliopathy Bardet-Biedl syndrome, with GPCRs failing to localize to cilia,
      indicating the Bardet-Biedl syndrome proteins are required for trafficking
      of G protein-coupled receptors into neuronal cilia.
    explanation: >-
      This mouse study directly supports defective ciliary cargo trafficking as a
      general mechanistic consequence of BBS protein loss.
  downstream:
  - target: Hypothalamic leptin receptor signaling defect
    description: Impaired neuronal ciliary trafficking perturbs hypothalamic satiety signaling.
  - target: Photoreceptor outer-segment transport defect
    description: High-throughput photoreceptor cargo delivery fails when ciliary trafficking is disrupted.
  - target: Renal tubulointerstitial injury
    description: Kidney epithelial cilia-dependent homeostasis is disrupted downstream of trafficking failure.
  - target: Altered Sonic hedgehog-dependent limb patterning
    description: Developmental ciliary signaling defects perturb limb-bud patterning.
- name: Hypothalamic leptin receptor signaling defect
  conforms_to: "ciliopathy_dysfunction#Hypothalamic Ciliary Signaling and Metabolic Dysfunction"
  description: >-
    BBS proteins are required for leptin-receptor trafficking and
    leptin-induced hypothalamic signaling, creating ciliary leptin resistance
    and impaired satiety signaling.
  cell_types:
  - preferred_term: neuron
    term:
      id: CL:0000540
      label: neuron
  locations:
  - preferred_term: hypothalamus
    term:
      id: UBERON:0001898
      label: hypothalamus
  biological_processes:
  - preferred_term: JAK-STAT signaling
    term:
      id: GO:0007259
      label: cell surface receptor signaling pathway via JAK-STAT
  evidence:
  - reference: PMID:19150989
    reference_title: "Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Our data indicate that BBS proteins mediate LepR trafficking and that
      impaired LepR signaling underlies energy imbalance in BBS.
    explanation: >-
      This mouse study directly connects BBS-protein loss to defective
      hypothalamic leptin receptor trafficking and signaling.
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with BBS had higher leptin than expected for their degree of
      adiposity, consistent with the notion that ciliopathy-induced leptin
      signaling dysfunction is associated with leptin resistance.
    explanation: >-
      Human metabolic data support leptin resistance as a clinically observable
      consequence of BBS-related satiety-pathway dysfunction.
  downstream:
  - target: Hyperphagia
    description: Impaired satiety signaling increases hunger and food-seeking behavior.
  - target: Obesity
    description: Chronic positive energy balance drives early-onset obesity.
- name: Photoreceptor outer-segment transport defect
  conforms_to: "ciliopathy_dysfunction#Photoreceptor Connecting Cilium Degeneration"
  description: >-
    In photoreceptors, defective ciliary transport mislocalizes rhodopsin and
    other outer-segment cargo, leading to photoreceptor degeneration.
  cell_types:
  - preferred_term: photoreceptor cell
    term:
      id: CL:0000210
      label: photoreceptor cell
  locations:
  - preferred_term: retina
    term:
      id: UBERON:0000966
      label: retina
  cellular_components:
  - preferred_term: photoreceptor outer segment
    term:
      id: GO:0001750
      label: photoreceptor outer segment
  evidence:
  - reference: PMID:15539463
    reference_title: "Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Photoreceptor cell death is preceded by mislocalization of rhodopsin,
      indicating a defect in transport.
    explanation: >-
      This model-organism study directly ties BBS-related transport failure to
      the retinal degeneration branch of the disease.
  downstream:
  - target: Rod-cone dystrophy
    description: Photoreceptor degeneration produces the invariant retinal dystrophy phenotype.
  - target: Progressive visual loss
    description: Ongoing photoreceptor loss causes worsening visual acuity over time.
- name: Renal tubulointerstitial injury
  conforms_to: "ciliopathy_dysfunction#Renal Tubular Cystic and Fibrotic Disease"
  description: >-
    Kidney involvement in BBS includes renal dysmorphism, impaired kidney
    function, and chronic tubulointerstitial disease consistent with a renal
    ciliopathy.
  cell_types:
  - preferred_term: nephron tubule epithelial cell
    term:
      id: CL:1000494
      label: nephron tubule epithelial cell
  locations:
  - preferred_term: kidney
    term:
      id: UBERON:0002113
      label: kidney
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Renal abnormalities, including impairment of renal function and signs of
      chronic interstitial nephropathy of dysplastic nature, were documented in
      82% of the patients.
    explanation: >-
      This human cohort provides direct tissue-level support for renal
      tubulointerstitial disease within BBS.
  downstream:
  - target: Renal abnormalities
    description: Structural and functional kidney disease is a major clinical consequence.
- name: Altered Sonic hedgehog-dependent limb patterning
  conforms_to: "ciliopathy_dysfunction#Impaired Hedgehog Signal Transduction"
  description: >-
    BBS loss perturbs cilia-dependent Sonic hedgehog signaling during limb-bud
    development, predisposing to postaxial digit duplication.
  biological_processes:
  - preferred_term: smoothened signaling pathway
    term:
      id: GO:0007224
      label: smoothened signaling pathway
  locations:
  - preferred_term: limb bud
    term:
      id: UBERON:0004347
      label: limb bud
  evidence:
  - reference: PMID:18381349
    reference_title: "Genetic interaction between Bardet-Biedl syndrome genes and implications for limb patterning."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We evaluated zebrafish fin bud patterning and observed altered Sonic
      hedgehog (shh) expression and subsequent changes to fin skeletal elements.
    explanation: >-
      This in vivo developmental study supports altered hedgehog-dependent limb
      patterning as the mechanistic basis for BBS polydactyly.
  downstream:
  - target: Postaxial polydactyly
    description: Disrupted limb-bud patterning manifests clinically as postaxial extra digits.
phenotypes:
- name: Rod-cone dystrophy
  category: Ocular
  frequency: VERY_FREQUENT
  diagnostic: true
  description: >-
    Invariant retinal dystrophy with early rod dysfunction, progressive retinal
    degeneration, and severe visual morbidity over time.
  phenotype_term:
    preferred_term: rod-cone dystrophy
    term:
      id: HP:0000510
      label: Rod-cone dystrophy
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All patients had retinal dystrophy with morphologic changes of the retina.
    explanation: >-
      This specialist ophthalmic cohort supports retinal dystrophy as an
      essentially invariant feature of molecularly confirmed BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients ... Retinal
      dystrophy was the most common feature (94.1%), followed by polydactyly
      (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      Molecularly confirmed BBS cohort (subject made explicit): retinal dystrophy
      at 94.1% supports the very frequent band, scoped to true BBS rather than the
      BBSome-opathy spectrum.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000556 | Retinal dystrophy | Obligate (100%)"
    explanation: >-
      Orphanet classifies retinal dystrophy as obligate (100%) in
      Bardet-Biedl syndrome, supporting the very frequent designation.
- name: Progressive visual loss
  category: Ocular
  description: >-
    Visual acuity progressively declines from childhood, often reaching severe
    impairment or blindness in later decades.
  phenotype_term:
    preferred_term: progressive visual loss
    term:
      id: HP:0000529
      label: Progressive visual loss
  evidence:
  - reference: PMID:35886001
    reference_title: "Ophthalmic and Genetic Features of Bardet Biedl Syndrome in a German Cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Visual acuity decreased from ~0.2 (decimal) at age 5 to blindness 0 at 50
      years.
    explanation: >-
      This cohort provides direct longitudinal-style evidence for progressive
      loss of vision across the lifespan in BBS.
  - reference: PMID:22358239
    reference_title: "Visual acuity and retinal function in patients with Bardet-Biedl syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a relatively young cohort of patients with Bardet-Biedl syndrome, only
      21% had 20/40 or better vision.
    explanation: >-
      This retinal-function study supports clinically important visual loss even
      in a relatively young cohort.
- name: Obesity
  category: Metabolic
  frequency: VERY_FREQUENT
  description: >-
    Rapid early-childhood weight gain leads to persistent overweight or obesity
    through childhood and adulthood.
  phenotype_term:
    preferred_term: obesity
    term:
      id: HP:0001513
      label: Obesity
  evidence:
  - reference: PMID:32700463
    reference_title: "Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS is typified by obesity in adulthood ... most individuals with BBS
      experience rapid weight gain in early childhood, with high rates of
      overweight/obesity sustained through adolescence.
    explanation: >-
      Registry-based study of BBS patients: obesity is age-dependent, typifying
      adulthood (supporting the very frequent band) while building from early
      childhood. The subject is explicitly BBS, not the broader BBSome-opathy
      spectrum.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients ... obesity
      (68.0%)
    explanation: >-
      In this molecularly confirmed BBS cohort obesity was recorded in 68%; the
      figure is lower than the adult-typified very frequent band because the
      cohort is pediatric-inclusive, illustrating the cohort-dependence of the
      frequency. Subject is confirmed BBS.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0001513 | Obesity | Very frequent (99-80%)"
    explanation: >-
      Orphanet classifies obesity as very frequent (99-80%) in Bardet-Biedl
      syndrome.
- name: Hyperphagia
  category: Behavioral
  description: >-
    Pathologic hunger and food-seeking behavior contribute to the obesity burden
    in BBS.
  phenotype_term:
    preferred_term: hyperphagia
    term:
      id: HP:0002591
      label: Polyphagia
  evidence:
  - reference: PMID:23776152
    reference_title: "Hyperphagia among patients with Bardet-Biedl syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Total hyperphagia questionnaire score was higher in BBS than controls
      (27.6 ± 9.0 vs. 19.1 ± 7.9, P = 0.005).
    explanation: >-
      This controlled study shows that hyperphagic symptoms are increased in BBS
      relative to BMI-matched controls.
- name: Postaxial polydactyly
  category: Skeletal
  frequency: FREQUENT
  diagnostic: true
  description: >-
    Postaxial extra digits affecting hands or feet are a cardinal developmental
    manifestation of BBS.
  phenotype_term:
    preferred_term: postaxial polydactyly
    term:
      id: HP:0100259
      label: Postaxial polydactyly
  evidence:
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients ... Retinal
      dystrophy was the most common feature (94.1%), followed by polydactyly
      (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      Molecularly confirmed BBS cohort (subject made explicit): polydactyly at
      88% supports the frequent band in true BBS.
  - reference: PMID:30614526
    reference_title: "Bardet-Biedl syndrome: Antenatal presentation of forty-five fetuses with biallelic pathogenic variants in known Bardet-Biedl syndrome genes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report here the largest cohort of BBS fetuses to better characterize
      the antenatal presentation ... postaxial polydactyly (82%) and renal cysts
      (78%) were the most prevalent symptoms.
    explanation: >-
      Independent support for frequent postaxial polydactyly; the subject is made
      explicit as a molecularly confirmed antenatal (fetal) BBS cohort, whose
      ascertainment differs from postnatal clinical series.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0100259 | Postaxial polydactyly | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies postaxial polydactyly as frequent (79-30%) in
      Bardet-Biedl syndrome.
- name: Renal abnormalities
  category: Genitourinary
  frequency: FREQUENT
  description: >-
    Structural and functional kidney disease includes renal dysmorphism, cystic
    or dysplastic change, and impaired kidney function.
  phenotype_term:
    preferred_term: renal abnormalities
    term:
      id: HP:0000077
      label: Abnormality of the kidney
  evidence:
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Renal abnormalities, including impairment of renal function and signs of
      chronic interstitial nephropathy of dysplastic nature, were documented in
      82% of the patients.
    explanation: >-
      This national cohort supports renal involvement as a frequent and
      clinically important component of BBS.
  - reference: PMID:41219488
    reference_title: "Comprehensive clinical and genetic characterization of Bardet-Biedl Syndrome: insights from the largest Turkish cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants were identified in all patients ... Retinal
      dystrophy was the most common feature (94.1%), followed by polydactyly
      (88.0%), obesity (68.0%), and renal anomalies (52.0%).
    explanation: >-
      Molecularly confirmed BBS cohort (subject made explicit): renal involvement
      at 52% remains common but more variable than retinal disease or
      polydactyly, scoped to true BBS.
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0012622 | Chronic kidney disease | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies chronic kidney disease as frequent in BBS, supporting
      the clinical importance of renal involvement.
- name: Hypogonadism
  category: Endocrine
  frequency: FREQUENT
  description: >-
    Hypogonadism is a cardinal feature of BBS, manifesting as micropenis and
    cryptorchidism in males, and ovarian and uterine hypoplasia in females.
  phenotype_term:
    preferred_term: hypogonadism
    term:
      id: HP:0000135
      label: Hypogonadism
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000135 | Hypogonadism | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies hypogonadism as frequent (79-30%) in Bardet-Biedl
      syndrome.
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bardet-Biedl Syndrome (BBS) is a rare autosomal recessive ciliopathy with a
      wide spectrum of clinical features including obesity, retinitis pigmentosa,
      polydactyly, mental retardation, hypogonadism, and renal abnormalities.
    explanation: >-
      This cohort explicitly lists hypogonadism among the cardinal clinical
      features of BBS.
- name: Neurodevelopmental delay
  category: Neurological
  frequency: VERY_FREQUENT
  description: >-
    Neurodevelopmental delay is a very frequent feature of BBS, with variable
    severity ranging from mild learning difficulties to more significant
    cognitive impairment.
  phenotype_term:
    preferred_term: neurodevelopmental delay
    term:
      id: HP:0012758
      label: Neurodevelopmental delay
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0012758 | Neurodevelopmental delay | Very frequent (99-80%)"
    explanation: >-
      Orphanet classifies neurodevelopmental delay as very frequent (99-80%)
      in Bardet-Biedl syndrome.
- name: Learning disability
  category: Neurological
  frequency: FREQUENT
  description: >-
    Specific learning disability is common in BBS, affecting academic
    performance independent of overall intellectual ability.
  phenotype_term:
    preferred_term: specific learning disability
    term:
      id: HP:0001328
      label: Specific learning disability
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0001328 | Specific learning disability | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies specific learning disability as frequent (79-30%)
      in Bardet-Biedl syndrome.
- name: Brachydactyly
  category: Skeletal
  frequency: FREQUENT
  description: >-
    Short digits are a frequent skeletal feature in BBS, often accompanying
    postaxial polydactyly.
  phenotype_term:
    preferred_term: brachydactyly
    term:
      id: HP:0001156
      label: Brachydactyly
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0001156 | Brachydactyly | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies brachydactyly as frequent (79-30%) in Bardet-Biedl
      syndrome.
- name: Hypertension
  category: Cardiovascular
  frequency: FREQUENT
  description: >-
    Systemic hypertension is frequent in BBS, likely related to renal disease
    and obesity.
  phenotype_term:
    preferred_term: hypertension
    term:
      id: HP:0000822
      label: Hypertension
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000822 | Hypertension | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies hypertension as frequent (79-30%) in Bardet-Biedl
      syndrome.
  - reference: PMID:20876674
    reference_title: "Bardet-Biedl syndrome: a study of the renal and cardiovascular phenotypes in a French cohort."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Hypertension was found in >30% of the patients and hyperlipidemia in
      >60%
    explanation: >-
      This French cohort directly documents hypertension prevalence exceeding
      30% in BBS patients.
- name: Hypertriglyceridemia
  category: Metabolic
  frequency: FREQUENT
  description: >-
    Elevated triglycerides are a frequent metabolic feature of BBS,
    contributing to the cardiometabolic risk profile.
  phenotype_term:
    preferred_term: hypertriglyceridemia
    term:
      id: HP:0002155
      label: Hypertriglyceridemia
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0002155 | Hypertriglyceridemia | Frequent (79-30%)"
    explanation: >-
      Orphanet classifies hypertriglyceridemia as frequent (79-30%) in
      Bardet-Biedl syndrome.
- name: Hearing impairment
  category: Sensory
  frequency: OCCASIONAL
  description: >-
    Sensorineural or mixed hearing loss occurs occasionally in BBS.
  phenotype_term:
    preferred_term: hearing impairment
    term:
      id: HP:0000365
      label: Hearing impairment
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0000365 | Hearing impairment | Occasional (29-5%)"
    explanation: >-
      Orphanet classifies hearing impairment as occasional (29-5%) in
      Bardet-Biedl syndrome.
  - reference: PMID:28143435
    reference_title: "Genetic characterization of Italian patients with Bardet-Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      BBS10 was associated with the worse outcome in terms of the renal, ocular
      and audiovestibular phenotypes.
    explanation: >-
      This Italian cohort documents audiovestibular involvement in BBS,
      particularly associated with BBS10 genotype.
- name: Hepatic fibrosis
  category: Hepatic
  frequency: OCCASIONAL
  description: >-
    Hepatic fibrosis and steatosis occur occasionally in BBS, reflecting
    ciliary dysfunction in hepatobiliary epithelium.
  phenotype_term:
    preferred_term: hepatic fibrosis
    term:
      id: HP:0001395
      label: Hepatic fibrosis
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0001395 | Hepatic fibrosis | Occasional (29-5%)"
    explanation: >-
      Orphanet classifies hepatic fibrosis as occasional (29-5%) in
      Bardet-Biedl syndrome.
- name: Type II diabetes mellitus
  category: Metabolic
  frequency: OCCASIONAL
  description: >-
    Type 2 diabetes mellitus occurs occasionally in BBS, related to insulin
    resistance and obesity.
  phenotype_term:
    preferred_term: type II diabetes mellitus
    term:
      id: HP:0005978
      label: Type II diabetes mellitus
  evidence:
  - reference: ORPHA:110
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "HP:0005978 | Type II diabetes mellitus | Occasional (29-5%)"
    explanation: >-
      Orphanet classifies type II diabetes mellitus as occasional (29-5%)
      in Bardet-Biedl syndrome.
biochemical:
- name: Leptin
  presence: Increased
  biomarker_term:
    preferred_term: leptin measurement
    term:
      id: NCIT:C74866
      label: Leptin Measurement
  notes: >-
    Serum leptin is elevated beyond what would be expected for adiposity alone,
    supporting clinical leptin resistance.
  evidence:
  - reference: PMID:21209035
    reference_title: "Patients with Bardet-Biedl syndrome have hyperleptinemia suggestive of leptin resistance."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with BBS had higher leptin than expected for their degree of
      adiposity, consistent with the notion that ciliopathy-induced leptin
      signaling dysfunction is associated with leptin resistance.
    explanation: >-
      This metabolic study supports hyperleptinemia as a human biochemical
      correlate of leptin resistance in BBS.
treatments:
- name: Setmelanotide
  description: >-
    MC4R agonist pharmacotherapy that bypasses upstream ciliopathy-related
    satiety-pathway dysfunction and reduces bodyweight in Bardet-Biedl syndrome.
  treatment_term:
    preferred_term: targeted therapy
    term:
      id: NCIT:C93352
      label: Targeted Therapy
    therapeutic_agent:
    - preferred_term: setmelanotide
      term:
        id: NCIT:C152349
        label: Setmelanotide
  target_phenotypes:
  - preferred_term: obesity
    term:
      id: HP:0001513
      label: Obesity
  evidence:
  - reference: PMID:36356613
    reference_title: "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      32·3% (95% CI 16·7 to 51·4; p=0·0006) of patients aged 12 years or older
      with Bardet-Biedl syndrome reached at least a 10% reduction in bodyweight
      after 52 weeks of setmelanotide.
    explanation: >-
      This phase 3 trial provides direct evidence that MC4R agonism can reduce
      bodyweight in BBS.
  - reference: PMID:36356613
    reference_title: "Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results support the use of setmelanotide and provided the necessary
      evidence for approval of this drug as the first treatment for obesity in
      patients with Bardet-Biedl syndrome.
    explanation: >-
      The trial interpretation explicitly supports setmelanotide as the approved
      obesity-directed treatment for BBS.
- name: Kidney transplantation
  description: >-
    Organ transplantation is a viable treatment option for the subset of BBS
    patients who progress to end-stage renal disease.
  treatment_term:
    preferred_term: organ transplantation
    term:
      id: MAXO:0010039
      label: organ transplantation
  evidence:
  - reference: PMID:27245600
    reference_title: "Renal transplantation in Bardet-Biedl Syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although the frequency of obesity and other manifestations of the
      metabolic syndrome warrant meticulous management in this high-risk
      population, favorable long-term outcomes suggest that renal
      transplantation is a viable option for patients with BBS and ESRD.
    explanation: >-
      This registry-based transplant study supports kidney transplantation for
      the ESRD subset of BBS.
references:
- reference: PMID:20301537
  title: Bardet-Biedl Syndrome Overview.
  tags:
  - GeneReviews
  findings: []
📚

References & Deep Research

References

1
PMID:20301537
Bardet-Biedl Syndrome Overview.
No top-level findings curated for this source.

Deep Research

3
Disorder ▸

Disorder

  • Name: Bardet-Biedl Syndrome
  • Category: Genetic
  • Existing deep-research providers: falcon
  • Existing evidence reference count in YAML: 97

Key Pathophysiology Nodes

  • Ciliary Dysfunction
  • BBSome Assembly and Intraflagellar Transport Defects
  • Hypothalamic Leptin Resistance
  • Renal Ciliary Dysfunction
  • Deep research literature mapping

Citation Inventory (for evidence mapping)

  • DOI:10.1080/14656566.2023.2199152
  • DOI:10.1101/cshperspect.a041303
  • DOI:10.2147/tcrm.s338653
Falcon ▸
Disease Pathophysiology Research Report
Edison Scientific Literature 17 citations 2025-12-15T09:08:14.659411

Disease Pathophysiology Research Report

Target Disease

  • Disease Name: Bardet–Biedl Syndrome (BBS)
  • MONDO ID: MONDO:0012746
  • Category: Genetic (autosomal recessive ciliopathy)

Pathophysiology Description

Bardet–Biedl syndrome is a prototypical non-motile ciliopathy caused by defects in proteins that localize predominantly to the primary cilium and its basal body/transition zone, leading to impaired ciliary compartmentalization and trafficking of membrane and signaling proteins across tissues including retina, kidney, and hypothalamus (energy balance) (melluso2023bardetbiedlsyndromecurrent pages 1-3). Mechanistically, BBS proteins assemble into the octameric BBSome with support from a dedicated chaperonin-like complex (BBS6/MKKS, BBS10, BBS12) and interface with intraflagellar transport (IFT) to regulate ciliary entry/retention and retrieval of G-protein–coupled receptors (GPCRs) and other membrane cargos (melluso2023bardetbiedlsyndromecurrent pages 1-3, melluso2023bardetbiedlsyndromecurrent pages 17-18). In photoreceptors, disruption of BBSome/IFT-mediated trafficking across the connecting cilium (“ciliary gate”) causes mislocalization of outer-segment proteins and triggers cell death and retinal degeneration (delvallee2023retinaldegenerationanimal pages 2-4). The multisystem phenotype reflects shared dependence on ciliary signaling and compartmentalization across organs (melluso2023bardetbiedlsyndromecurrent pages 1-3).

Direct quotes highlighting core mechanisms: - “The BBSome is defined as an octameric complex (BBS1/2/4/5/7/8/9/BBIP1) whose assembly requires chaperonin-like proteins (BBS6, BBS10, BBS12)… A functional link to the BBS3 GTPase enables intraflagellar transport (IFT)” (DOI: 10.2147/TCRM.S338653) (melluso2023bardetbiedlsyndromecurrent pages 1-3). - In photoreceptors “more than 1000 rhodopsin molecules [are] transiting per second… Defective IFT or BBSome-mediated trafficking causes abnormal protein trafficking across the [connecting cilium], provoking proapoptotic reactions and photoreceptor degeneration” (DOI: 10.1101/cshperspect.a041303) (delvallee2023retinaldegenerationanimal pages 2-4).

1. Core Pathophysiology

  • Primary mechanisms: impaired ciliary trafficking and gatekeeping due to BBSome/chaperonin dysfunction; defective cooperation with IFT-A/IFT-B disrupts anterograde/retrograde transport of ciliary cargos (melluso2023bardetbiedlsyndromecurrent pages 1-3, delvallee2023retinaldegenerationanimal pages 2-4).
  • Dysregulated pathways: ciliary GPCR signaling (e.g., leptin, serotonin 5-HT2C) and related neuronal energy-balance pathways; broad perturbation of ciliary signal transduction and proteostasis within the ciliary compartment (melluso2023bardetbiedlsyndromecurrent pages 14-15, melluso2023bardetbiedlsyndromecurrent pages 1-3).
  • Affected cellular processes: ciliary cargo sorting, membrane protein localization, GPCR trafficking, transition-zone gating, and IFT-driven transport; secondary degeneration from protein mislocalization in highly polarized cells (photoreceptors) (delvallee2023retinaldegenerationanimal pages 2-4, melluso2023bardetbiedlsyndromecurrent pages 1-3, melluso2023bardetbiedlsyndromecurrent pages 14-15).

2. Key Molecular Players

  • Genes/Proteins (HGNC): BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, BBS9, BBIP1 (BBS18), BBS6/MKKS, BBS10, BBS12 (BBS chaperonins); ARL6/BBS3 (small GTPase recruiting BBSome); IFT-B (e.g., IFT25/IFT27, IFT74/IFT81), IFT-A subunits (melluso2023bardetbiedlsyndromecurrent pages 1-3, delvallee2023retinaldegenerationanimal pages 2-4, lazareva2023anevaluationof pages 16-18).
  • Evidence: “Multiple BBSome components… and chaperonin-complex members… are explicitly annotated, indicating roles in BBSome assembly and… ciliary trafficking… [and] intraflagellar transport proteins (IFT27, IFT172, IFT74)” (DOI: 10.1080/14656566.2023.2199152) (lazareva2023anevaluationof pages 16-18).
  • Chemical entities (CHEBI)/drugs: Setmelanotide, an MC4R agonist, reduces hyperphagia and weight in BBS; additional small-molecule strategies include read-through agents (e.g., ataluren/amlexanox) for nonsense alleles (melluso2023bardetbiedlsyndromecurrent pages 12-14, lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).
  • Cell types (CL): Photoreceptors (rods/cones), hypothalamic POMC neurons, renal tubular epithelial cells (delvallee2023retinaldegenerationanimal pages 2-4, melluso2023bardetbiedlsyndromecurrent pages 14-15).
  • Anatomical locations (UBERON): Retina (photoreceptor outer/inner segments, connecting cilium), kidney (renal tubules), hypothalamus (arcuate nucleus/POMC neurons) (delvallee2023retinaldegenerationanimal pages 2-4, melluso2023bardetbiedlsyndromecurrent pages 14-15).

3. Biological Processes (GO terms; disrupted)

  • Ciliary transport and organization: cilium assembly (GO:0060271), ciliary transport (GO:0042073), protein localization to cilium (GO:0061512), ciliary GPCR signaling (e.g., response to peptide hormone) (melluso2023bardetbiedlsyndromecurrent pages 1-3, delvallee2023retinaldegenerationanimal pages 2-4, melluso2023bardetbiedlsyndromecurrent pages 14-15).
  • Intraflagellar transport: anterograde IFT (GO:0035721), retrograde IFT (GO:0035720) (delvallee2023retinaldegenerationanimal pages 2-4).
  • Membrane protein trafficking and proteostasis: protein targeting to membrane (GO:0006612); regulation of receptor localization and signaling (melluso2023bardetbiedlsyndromecurrent pages 14-15).
  • Photoreceptor maintenance and visual perception: phototransduction (GO:0007602); outer segment organization (delvallee2023retinaldegenerationanimal pages 2-4).

4. Cellular Components (GO/CL/UBERON)

  • Primary cilium (GO:0005929), basal body (GO:0005932), transition zone/connecting cilium (GO:0035869), periciliary membrane compartment (GO:0031526) (delvallee2023retinaldegenerationanimal pages 2-4, melluso2023bardetbiedlsyndromecurrent pages 1-3).
  • Photoreceptor outer segment (GO:0001750) and inner segment (GO:0001917) (delvallee2023retinaldegenerationanimal pages 2-4).
  • BBSome complex (GO:0034464), IFT-A/B complexes (GO:0030990/GO:0030991) (melluso2023bardetbiedlsyndromecurrent pages 1-3, delvallee2023retinaldegenerationanimal pages 2-4).

5. Disease Progression

  • Initiation: biallelic variants in BBSome/chaperonin/IFT-associated genes impair BBSome assembly and BBSome–IFT coupling, compromising ciliary entry/retention/retrieval of key receptors and channels (melluso2023bardetbiedlsyndromecurrent pages 1-3, lazareva2023anevaluationof pages 16-18).
  • Cellular dysfunction: disrupted trafficking across the transition zone/connecting cilium causes mislocalization of ciliary GPCRs and photoreceptor outer-segment proteins; in photoreceptors, continuous high-throughput trafficking demand makes them particularly vulnerable, leading to degeneration (delvallee2023retinaldegenerationanimal pages 2-4).
  • Organ-level manifestations: progressive rod–cone dystrophy with early nyctalopia and vision loss; renal concentrating/diluting defects and progressive CKD; severe hyperphagia/obesity from hypothalamic ciliary signaling disruption (e.g., leptin/5-HT2C/MC4R axis) (melluso2023bardetbiedlsyndromecurrent pages 14-15, lazareva2023anevaluationof pages 8-11).

6. Phenotypic Manifestations (HP terms)

  • Retinal dystrophy/rod–cone dystrophy (HP:0000510), nyctalopia (HP:0000662), progressive vision loss (HP:0000572) (delvallee2023retinaldegenerationanimal pages 2-4, lazareva2023anevaluationof pages 16-18).
  • Polydactyly (HP:0010442), postaxial (HP:0100259) (lazareva2023anevaluationof pages 16-18).
  • Obesity (HP:0001513), hyperphagia (HP:0002591) (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).
  • Renal anomalies/CKD (HP:0000077) and urine concentration defects (HP:0004743) (melluso2023bardetbiedlsyndromecurrent pages 14-15).
  • Learning difficulties (HP:0001328), hypogonadism (HP:0000135) (lazareva2023anevaluationof pages 16-18).

Tissue-Specific Mechanisms

  • Retina: Photoreceptor outer segments are modified cilia. The connecting cilium is a stringent gate; failure of BBSome/IFT trafficking causes mislocalization (e.g., rhodopsin) and photoreceptor death. Quote: “Defective IFT or BBSome-mediated trafficking… provoking proapoptotic reactions and photoreceptor degeneration” (DOI: 10.1101/cshperspect.a041303) (delvallee2023retinaldegenerationanimal pages 2-4).
  • Kidney: Renal tubular epithelial cilia regulate solute handling and signaling; BBS-related ciliary dysfunction correlates with concentrating/diluting defects and progressive renal disease (AQP2/UMOD changes), consistent with a ciliopathy framework (melluso2023bardetbiedlsyndromecurrent pages 14-15).
  • Hypothalamus/metabolism: Ciliary localization and trafficking of GPCRs (e.g., serotonin 5‑HT2C, leptin receptor) in POMC neurons are BBSome-dependent; mistrafficking impairs melanocortin signaling and contributes to hyperphagia and obesity (melluso2023bardetbiedlsyndromecurrent pages 14-15). Setmelanotide (MC4R agonist) pharmacologically restores downstream signaling, improving weight and hunger measures (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).

Recent Developments and Latest Research (prioritized 2023–2024)

  • 2023 review and updates: Comprehensive overviews emphasize BBSome–IFT cooperation, tissue mechanisms, and emerging therapies, with curated references to newer mechanistic work on IFT–BBS interfaces and ciliary trafficking (DOI: 10.2147/TCRM.S338653; Jan 2023) (melluso2023bardetbiedlsyndromecurrent pages 17-18, melluso2023bardetbiedlsyndromecurrent pages 1-3).
  • Retinal ciliopathy mechanisms: Authoritative 2023 perspective details modular ciliary organization (BBSome, IFT-A/B, transition zone), high flux of photoreceptor cargo, and how trafficking failure leads to degeneration (DOI: 10.1101/cshperspect.a041303; Jan 2023) (delvallee2023retinaldegenerationanimal pages 2-4).
  • Therapeutics for BBS obesity: 2023 expert evaluation consolidates clinical data for setmelanotide in BBS, with mechanistic rationale via MC4R pathway rescue and details of diagnostic criteria—supporting translation of ciliary signaling knowledge to treatment (DOI: 10.1080/14656566.2023.2199152; Apr 2023) (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).

Note: Although additional 2023–2024 mechanistic advances (e.g., BBSome ubiquitylation, TOM1L2-mediated ubiquitin recognition, refined IFT-B interfaces, EV/ectocytosis, and cAMP microdomains in cilia) are widely reported in the field, they were not present in the retrieved evidence excerpts and thus are not detailed here.

Current Applications and Real-World Implementations

  • Setmelanotide (MC4R agonist) for BBS-associated hyperphagia/obesity: clinical use with evidence of weight loss and reduced hunger burden in BBS, aligning with hypothalamic ciliary signaling pathophysiology (DOI: 10.1080/14656566.2023.2199152; Apr 2023) (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).
  • Gene- and RNA-targeted strategies under investigation: readthrough therapy (ataluren/amlexanox) for nonsense alleles restored BBS2 and ciliogenesis in preclinical models; splicing correction tactics (snRNA/ASO) proposed; ocular gene therapy paradigms inform BBS pipelines (DOI: 10.2147/TCRM.S338653; Jan 2023) (melluso2023bardetbiedlsyndromecurrent pages 12-14).

Expert Opinions and Authoritative Analyses

  • Therapeutics and Clinical Risk Management review (Melluso et al., 2023) provides a consensus-style synthesis across molecular mechanisms, clinical spectrum, and translational avenues, underscoring the centrality of ciliary dysfunction and BBSome–IFT defects to pathogenesis (DOI: 10.2147/TCRM.S338653) (melluso2023bardetbiedlsyndromecurrent pages 1-3, melluso2023bardetbiedlsyndromecurrent pages 12-14, melluso2023bardetbiedlsyndromecurrent pages 17-18).
  • Cold Spring Harbor Perspectives in Medicine (Delvallée & Dollfus, 2023) offers an organ-specific, mechanistic retina focus, highlighting the connecting cilium gate and extreme trafficking demands as the proximate cause of photoreceptor vulnerability (DOI: 10.1101/cshperspect.a041303) (delvallee2023retinaldegenerationanimal pages 2-4).

Relevant Statistics and Data from Recent Studies

  • Diagnostic criteria and frequency of features (summarized): primary features—retinal degeneration (~93%), polydactyly (63–81%), obesity (72–92%), genital anomalies, learning difficulties, renal anomalies—used in standard diagnostic rules (four primary or three primary plus two secondary features) (DOI: 10.1080/14656566.2023.2199152) (lazareva2023anevaluationof pages 16-18).
  • Therapeutic outcomes: clinical analyses of setmelanotide in BBS report reductions in hyperphagia and body weight, positioning MC4R activation as a targeted approach for BBS-associated obesity (DOI: 10.1080/14656566.2023.2199152) (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).

Gene/Protein Annotations (selected)

  • BBSome core: BBS1; BBS2; BBS4; BBS5; BBS7; BBS8; BBS9; BBIP1/BBS18 (GO:0034464) (melluso2023bardetbiedlsyndromecurrent pages 1-3).
  • Chaperonin-like assembly factors: BBS6/MKKS; BBS10; BBS12 (GO:0005813 basal body localization; BBSome assembly) (melluso2023bardetbiedlsyndromecurrent pages 1-3).
  • ARL6/BBS3: GTPase recruiting BBSome to membranes (GO:0035091) (melluso2023bardetbiedlsyndromecurrent pages 1-3, delvallee2023retinaldegenerationanimal pages 2-4).
  • IFT components: IFT25/IFT27 (interface with BBSome); IFT74/IFT81 (IFT-B) (delvallee2023retinaldegenerationanimal pages 2-4, lazareva2023anevaluationof pages 16-18).

Ontology Mappings

  • GO Biological Process: cilium assembly (GO:0060271); protein localization to cilium (GO:0061512); intraflagellar transport (GO:0042073); photoreceptor cell maintenance (GO:0045494).
  • GO Cellular Component: primary cilium (GO:0005929); ciliary transition zone (GO:0035869); photoreceptor outer segment (GO:0001750); BBSome (GO:0034464); IFT-A/B complexes (GO:0030990/GO:0030991).
  • HPO Phenotypes: HP:0000510 (Rod–cone dystrophy); HP:0000662 (Nyctalopia); HP:0001513 (Obesity); HP:0002591 (Hyperphagia); HP:0000077 (Renal anomaly); HP:0010442 (Postaxial polydactyly).
  • CL Cell Types: CL:0000746 (photoreceptor cell); CL:0002607 (hypothalamic neuron); CL:0002306 (renal epithelial cell).
  • UBERON Anatomy: UBERON:0000966 (retina); UBERON:0002048 (kidney); UBERON:0001898 (hypothalamus).
  • CHEBI Chemicals: CHEBI:61093 (setmelanotide; MC4R agonist) [drug class mapping; used clinically in BBS obesity].

Evidence Items

1) Melluso A, et al. Bardet–Biedl Syndrome: Current Perspectives and Clinical Outlook. Therapeutics and Clinical Risk Management. Jan 2023. DOI: 10.2147/TCRM.S338653; URL: https://doi.org/10.2147/TCRM.S338653 (melluso2023bardetbiedlsyndromecurrent pages 1-3, melluso2023bardetbiedlsyndromecurrent pages 12-14, melluso2023bardetbiedlsyndromecurrent pages 17-18, melluso2023bardetbiedlsyndromecurrent pages 14-15). 2) Delvallée C, Dollfus H. Retinal Degeneration Animal Models in Bardet–Biedl Syndrome and Related Ciliopathies. Cold Spring Harb Perspect Med. Jan 2023. DOI: 10.1101/cshperspect.a041303; URL: https://doi.org/10.1101/cshperspect.a041303 (delvallee2023retinaldegenerationanimal pages 2-4). 3) Lazareva J, Brady SM, Yanovski JA. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to Bardet–Biedl syndrome. Expert Opin Pharmacother. Apr 2023. DOI: 10.1080/14656566.2023.2199152; URL: https://doi.org/10.1080/14656566.2023.2199152 (lazareva2023anevaluationof pages 8-11, lazareva2023anevaluationof pages 16-18).

Limitations: Additional 2024 advances (e.g., revised European consensus diagnostic criteria; detailed molecular updates on ubiquitylation and ciliary ubiquitin readers; EV/ectocytosis and cAMP microdomains) are recognized in the field but were not included in the retrieved excerpts; thus, mechanistic claims here are limited to the cited 2023 sources and their referenced evidence (melluso2023bardetbiedlsyndromecurrent pages 17-18).

References

  1. (melluso2023bardetbiedlsyndromecurrent pages 1-3): Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, and Miriam Zacchia. Bardet-biedl syndrome: current perspectives and clinical outlook. Therapeutics and Clinical Risk Management, 19:115-132, Jan 2023. URL: https://doi.org/10.2147/tcrm.s338653, doi:10.2147/tcrm.s338653. This article has 91 citations and is from a peer-reviewed journal.

  2. (melluso2023bardetbiedlsyndromecurrent pages 17-18): Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, and Miriam Zacchia. Bardet-biedl syndrome: current perspectives and clinical outlook. Therapeutics and Clinical Risk Management, 19:115-132, Jan 2023. URL: https://doi.org/10.2147/tcrm.s338653, doi:10.2147/tcrm.s338653. This article has 91 citations and is from a peer-reviewed journal.

  3. (delvallee2023retinaldegenerationanimal pages 2-4): Clarisse Delvallée and Hélène Dollfus. Retinal degeneration animal models in bardet-biedl syndrome and related ciliopathies. Cold Spring Harbor perspectives in medicine, 13 1:a041303, Jan 2023. URL: https://doi.org/10.1101/cshperspect.a041303, doi:10.1101/cshperspect.a041303. This article has 12 citations and is from a peer-reviewed journal.

  4. (melluso2023bardetbiedlsyndromecurrent pages 14-15): Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, and Miriam Zacchia. Bardet-biedl syndrome: current perspectives and clinical outlook. Therapeutics and Clinical Risk Management, 19:115-132, Jan 2023. URL: https://doi.org/10.2147/tcrm.s338653, doi:10.2147/tcrm.s338653. This article has 91 citations and is from a peer-reviewed journal.

  5. (lazareva2023anevaluationof pages 16-18): Julia Lazareva, Sheila M. Brady, and Jack A. Yanovski. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to bardet–biedl syndrome. Expert Opinion on Pharmacotherapy, 24:667-674, Apr 2023. URL: https://doi.org/10.1080/14656566.2023.2199152, doi:10.1080/14656566.2023.2199152. This article has 13 citations and is from a peer-reviewed journal.

  6. (melluso2023bardetbiedlsyndromecurrent pages 12-14): Andrea Melluso, Floriana Secondulfo, Giovanna Capolongo, Giovambattista Capasso, and Miriam Zacchia. Bardet-biedl syndrome: current perspectives and clinical outlook. Therapeutics and Clinical Risk Management, 19:115-132, Jan 2023. URL: https://doi.org/10.2147/tcrm.s338653, doi:10.2147/tcrm.s338653. This article has 91 citations and is from a peer-reviewed journal.

  7. (lazareva2023anevaluationof pages 8-11): Julia Lazareva, Sheila M. Brady, and Jack A. Yanovski. An evaluation of setmelanotide injection for chronic weight management in adult and pediatric patients with obesity due to bardet–biedl syndrome. Expert Opinion on Pharmacotherapy, 24:667-674, Apr 2023. URL: https://doi.org/10.1080/14656566.2023.2199152, doi:10.1080/14656566.2023.2199152. This article has 13 citations and is from a peer-reviewed journal.

OpenAI ▸
Bardet-Biedl syndrome curation notes
gpt-5.4 17 citations 2026-04-13T01:21:32Z

Bardet-Biedl syndrome curation notes

Disease framing

  • Curate this as classic syndromic Bardet-Biedl syndrome, not as a loose bucket for every "BBS-like" ciliopathy.
  • Keep the disease-level entry unified because the core mechanistic story is shared across established BBS genes: defective BBSome-dependent ciliary cargo trafficking.
  • Capture genotype-specific severity differences in genetic: notes rather than exploding the entry into dozens of gene-specific subtypes. The strongest repeatedly supported contrasts are BBS1 versus BBS10.
  • Useful framing papers for this boundary:
  • PMID:30614526 states BBS is a heterogeneous ciliopathy with "22 known genes" and retains the classic syndrome definition.
  • PMID:41219488 and PMID:37031301 show continued heterogeneity across recent molecular cohorts.

Core mechanistic backbone

  1. Biallelic pathogenic variants in established BBS genes initiate disease. Representative human cohort support: PMID:30614526, PMID:41219488.
  2. These defects impair BBSome assembly or its chaperonin-assisted maturation. Best mechanistic assembly papers: PMID:22500027 and PMID:20080638.
  3. An incompletely assembled BBSome disrupts ciliary cargo trafficking. Neuronal GPCR-trafficking support: PMID:36699005.
  4. Tissue-specific consequences then branch:
  5. Hypothalamus: impaired LepR trafficking/signaling drives leptin resistance, hyperphagia, and obesity (PMID:19150989, PMID:21209035, PMID:23776152, PMID:32700463).
  6. Retina: rhodopsin mislocalization and photoreceptor death drive the invariant retinal dystrophy phenotype and progressive visual loss (PMID:15539463, PMID:35886001, PMID:22358239, PMID:41219488).
  7. Kidney: renal dysmorphism, impaired function, and chronic tubulointerstitial disease are frequent and prognostically important (PMID:20876674, PMID:41219488).
  8. Limb bud: altered Sonic hedgehog-dependent patterning explains postaxial polydactyly (PMID:18381349).

Human phenotype and genotype highlights

  • Retinal dystrophy is the most stable phenotype anchor.
  • PMID:35886001: all patients in the German ophthalmic cohort had retinal dystrophy.
  • PMID:41219488: retinal dystrophy 94.1%.
  • Polydactyly and obesity are frequent but less invariant than retinal disease.
  • PMID:41219488: polydactyly 88.0%, obesity 68.0%.
  • PMID:32700463: overweight/obesity exceeded 90% after age 5 in the large pediatric registry.
  • Kidney disease is common but more variable across cohorts.
  • PMID:20876674: renal abnormalities in 82%.
  • PMID:41219488: renal anomalies in 52.0%.
  • PMID:37031301: renal anomalies only 7.1% in that Chinese cohort, which is a reminder not to overstate invariance.
  • BBS1 and BBS10 are the most reproducibly common genotype groups in many cohorts.
  • PMID:35886001: BBS10 32.8%, BBS1 24.6%.
  • PMID:21209035: BBS10 30%, BBS1 27%.
  • PMID:28143435: BBS1 followed by BBS10.
  • BBS10 is the clearest severity signal.
  • PMID:28143435 links BBS10 to worse renal and ocular outcomes.
  • PMID:20876674 links BBS6/BBS10/BBS12 genotypes to more severe renal disease.

Treatment curation choices

  • Include setmelanotide because it has direct BBS phase 3 human evidence and a clear mechanistic rationale as downstream MC4R agonism (PMID:36356613).
  • Include kidney transplantation because registry data support it for the ESRD subset (PMID:27245600).
  • Do not overspecify generic supportive care unless the claim is directly abstract-supported for BBS itself.

Evidence-quality decisions

  • Prefer exact PMID-backed quotations from cohort abstracts or mechanistic abstracts over generic review prose.
  • Use HUMAN_CLINICAL for patient cohorts, registries, transplant series, and trials.
  • Use MODEL_ORGANISM for mouse or zebrafish mechanism papers.
  • Use OTHER only where the abstract itself mixes multiple experimental modes and cannot be cleanly split without misclassifying the publication-level evidence.

Claims intentionally downweighted or excluded

  • Broad "all BBS genes" lists beyond clearly established syndrome genes were not overexpanded into the YAML because the disease entry should stay syndrome-level and mechanistically coherent.
  • Behavioral, craniofacial, cardiac, and hearing findings were not made central pathophysiology nodes because the strongest disease-level mechanistic evidence is still the retina-hypothalamus-kidney-limb axis.
  • Histopathology was not added as a standalone section even though PMID:20876674 supports chronic interstitial nephropathy of dysplastic nature; the evidence is used directly in the renal pathophysiology and phenotype instead.